Adaptation of Barley Powdery Mildew (Blumeria graminis f. sp. hordei) in Western Australia to Contemporary Agricultural Practices by Tucker, Madeline Ann
School of Science 











Adaptation of Barley Powdery Mildew (Blumeria graminis f. sp. hordei) in Western 

















This thesis is presented for the Degree of 












3 | P a g e  
 
“To the best of my knowledge and belief this thesis contains no material previously published 
by any other person or accepted in the award of any other degree or diploma in any university 
except where due acknowledgment has been made.”  
 
 




The powdery mildew pathogen Blumeria graminis f. sp. hordei (Bgh) is a significant threat to 
barley production, but is controlled in most regions of the world through combinations of 
host genetics and fungicides. Unfortunately in recent years powdery mildew has emerged as 
the most damaging disease of barley in Western Australia (WA) where many of the currently 
available cultivars are susceptible to disease and therefore growers have had to rely almost 
exclusively on fungicides as the main method of disease control  
 
On a global scale Bgh is known to exist in numerous races or pathotypes each with a defined 
set of avirulence genes. Knowledge of the avirulence genes in the local population can be 
used to elucidate which major plant resistance genes (R-genes) may prove useful in current or 
future breeding strategies. Here sixty isolates of Bgh were collected from nine locations 
across Australia. Each was used to infect a set of cultivars with known R-genes for Bgh. A 
total of 18 unique pathotypes were identified and virulence against many of the R-genes were 
present in at least one pathotype. Undefeated genes included Mla-6, Mla-9, Ml-ra and the 
combinations of Mla-1 plus Mla-A12 and Mla-6 plus Mla-14 and Mla-13 plus Ml- Ru3 
together with recessive mlo-5. The data indicated some pathotype spatial differentiation 
suggesting local selection pressures and proliferation within different regions of WA. 
 
Highly polymorphic microsatellite or short sequence repeat (SSR) markers are additional 
tools that can be used to characterise diversity in pathogen populations. The number of short 
intergenic or intragenic repeats often varies between individuals. Thus SSR markers can be 
used to screen collections of isolates to elucidate intrinsic genetic relatedness. Despite the 
widespread colonisation of Bgh in many agriculturally important global cropping regions, as 
yet no SSR markers have been defined. Here, eight polymorphic microsatellite loci were 
identified and characterised. Primer pairs amplifying the loci were then applied to 111 
Australian isolates of Bgh. The number of alleles per locus ranged from 4 to 13, and Nei’s 
genetic diversity ranged from 0.25 to 0.76. The SSR primers detected several clones and 
defined 97 unique haplotypes. There was little evidence for regional genotypic subdivision, 
suggesting the movement of Bgh in the major Australian cropping areas remains largely 
unrestricted.  All data was consistent with high levels of genetic diversity, potentially 
resulting from random mating and spread within each region. 
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Recent reductions in the efficacy of triazole fungicides in WA suggest that resistance may 
have developed. Yields in affected paddocks were reduced by 25 to 40% and resulted in 
harvested grain being downgraded from malt to feed. To determine if Cyp51 (encoding 14α-
sterol demethylase; syn. ERG11) mutations were causing the reduction in triazole efficacy, 
the in vitro sensitivities of Bgh isolates to currently registered triazoles were obtained. Cyp51 
sequencing revealed five non-synonymous amino acid substitutions: Y136F, K171E, M301I, 
R327G and S509T. A clear association was established between combinations of mutations 
and altered levels of resistance to triazoles. Characterization of the mutations in a yeast 
expression system dissected the contribution of each mutation to the final resistant 
phenotype. Yeast genotypes harbouring the S509T mutation were less sensitive to all 
triazoles except fluquinconazole, which was more effective than other genotypes, exhibiting 
negative cross resistance. Protein structural modelling revealed a clear association between 
fungicide sensitivity and the heme cavity volume. Fluquinconazole docking studies 
confirmed the negative cross resistance. The in silico appraisal of binding efficiencies 
between specific triazoles and Cyp51 variants promises to facilitate the design of resistance 
management strategies that counter select the most abundant mutations and considerably 
extend the useful life of this critical group of fungicides. 
Previous European studies have predicted that the repeated use of fungicides of single mode 
of action can lead to fungicide resistance.  In Australia, contemporary agricultural practices 
have resulted in the utilisation of barley cultivars often harbouring a single dominant 
resistance gene for Bgh. Unfortunately resistance mediated in this manner has often proved to 
be short-lived, breaking down in as soon as a single season after wide scale exploitation. In 
WA, high disease incidence on susceptible cultivars has necessitated the application of 
fungicides for Bgh control – with each registered formulation containing a triazole. This 
study details the rapid adaptation of WA barley powdery mildew isolates, where with 
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7.0 Introduction and Overview 
 7.1 General Introduction 
 7.11 Powdery Mildew of Barley 
 
Powdery mildew fungi cause disease on most cultivated plants ranging from cereals and 
vegetables to fruit trees and ornamental plants. At present, 650 powdery mildew species have 
been defined infecting thousands of plant species (Braun, Cook et al. 2002). In cereals the 
disease is caused by Blumeria graminis which has adapted into separate forma specialis (ff. 
spp.) depending on host specificity. Blumeria graminis f. sp. hordei (Bgh) is classified in the 
fungal Division Ascomycota (producing non-motile spores, called ascospores, in an ascus), 
Class Leotiomycetes (having cylindrical asci, without operculum, that are developed in the 
apothecia), Order Erysiphales (with cleistothecia having asci arranged in a hymenial layer), 
Family Erysiphaceae, Genus Blumeria and Species graminis Forma specialis hordei (Braun, 
Cook et al. 2002). Bgh occurs throughout many of the barley growing regions of the world 
including southern Western Australia. Barley is the fourth most important crop in the world 
behind wheat, maize and rice (FAOSTAT 2014). In WA barley is of great economic 
importance producing on an average of 2.5M tonnes per annum (ABARES 2014). WA growers 
are renowned for producing high quality malt grade grain, the majority of which is exported, 
mainly for malt and Japanese shochu production but also for human and animal consumption 
(Paynter, Hills et al. 2011). In many parts of the world Bgh is controlled through combinations 
of host resistance and fungicide applications. In WA, foreign demand for malt grade grain has 
led to the majority of the barley cropping area being sown with mildew susceptible cultivars. 
Therefore growers in regions prone to infection have relied heavily on the application of 
fungicides for disease control.  
 
 7.12 Disease symptoms 
Barley powdery mildew infections are characterised by white to grey fluffy pustules which can 
occur on all aerial parts of the plant from the stem to the leaves and awns (Figure 1). Initial 
symptoms are usually on the abaxial surface of lower leaves and take the form of yellow 
chlorotic flecks. The development of white fluffy pustules follows rapidly which sprout masses 
of asexual conidia from the adaxial leaf surface. Cleistothecia (fruiting bodies forming sexual 
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spores) may develop late in the season and can be found embedded in the mildew pustules as 






Figure 1. Blumeria graminis f. sp. hordei infecting barley (Hordeum vulgare). 
 
Examples of pustule development on A) leaf tissue and B) awn. 
 
 
In cultivars with some level of resistance to Bgh infection it is also common to observe localised 
brownish regions of cell necrosis triggered by the activation of the plant innate hypersensitive 
response (Figure 2). Here, cultivars undergo localised cell apoptosis in the region of infection 
thereby starving the biotrophic pathogen of essential plant derived nutrients. 
 
In interactions that lead to disease (frequently called compatible interactions) or to immune 
responses (called incompatible interactions), it is not unusual to observe different stages of 
fungal development on a single leaf. The relative frequencies of the various developmental 
stages differ and this allows macroscopic discrimination of five infection types (ITs) ranging 
from IT0 to IT4 (Boyd, Smith et al. 1995; Thordal-Christensen, Gregersen et al. 2000). The 
coinciding developmental spectrum can be used to qualify the extent of interaction between 
host and pathogen and to gauge the level of host resistance or susceptibility. 
 
 






Figure 2. Various stages of development of Blumeria graminis f. sp. hordei. 
 
A) Complete plant resistance (IT0), B) The plant innate hypersensitive response has 
triggered the death of cells at localised infection points resulting in necrotic flecks (IT1), 
C) Plant incomplete resistance characterised by patches of necrosis with some 
sporulation (IT2-IT3), D) Complete plant susceptibility characterised by profuse 
sporulation and total lack of necrosis (IT4) and E) Sexual fruiting bodies, cleistothecia, 
permits overwintering of pathogen on crop debris. 
 
 
 7.13 Life Cycle and Epidemiology 
The dispersal of mildew occurs through the spread of asexual haploid conidia between 
susceptible host plants. The spores disseminate by wind and initiate a new infection cycle upon 
landing on neighbouring plants or by migrating up to hundreds of kilometres (Jørgensen, 1994; 
Thordal-Christensen et al., 2000). When a conidium lands on the leaf surface, infection 
structures begin to rapidly differentiate (Pascholati, Yoshioka et al. 1992). This begins with the 
development of two morphologically distinct germ tubes (Figure 3). The primary germ tube 
(PGT) appears approximately 2-4h after contact and is thought to be involved in adhesion and 
orientation, water acquisition and transduction of leaf derived signals (Heitefuss 2001; 
Eichmann and Hückelhoven 2008). Successful attachment drives the differentiation of the 
secondary tube, the appressorial germ tube (AGT), approximately four hours after initial 
contact. These early events on the epidermal surface of the leaf are of little relevance to the 
inherent susceptibility or resistance of the cultivar. The critical stage is the subsequent 
penetration phase, where the fungus attempts to enter the host cell wall via a penetration peg 









Figure 3. Diagram of the infection process of Blumeria graminis f. sp. hordei.  
 
A) A conidia lands on the barley leaf epidermis. B) Approximately 2-4h after adhesion the 
primary germ tube (PGT) is formed. C) A secondary tube, the appressorial germ tube 
(AGT) swell at the tip to form the appressorium (APPS). D) In susceptible hosts, the APPS 
forms a small peg which penetrates the barley leaf epidermis. Haustoria are formed 
within cells that assimilate host derived nutrients.  E) After approximately 72h after 
adhesion, conidiophore structures differentiate and form chains of asexual conidia. 
Adapted from Oliver (1998). 
  
   
 
   
  
   
    
   
    
   














16 | P a g e  
 
The appressorial germ tube swells at the tip producing a lobed appressorium (APPS). The 
APPS forms a small peg which penetrates the plant cell wall making contact with the plasma 
membrane of a leaf epidermal cell (Figure 3). Penetration through the epidermal cell wall is a 
critical stage in the infection process and plant defence mechanisms are induced in order to 
resist fungal entry at this point. Such mechanisms include a combination of site –directed 
cytoplasmic streaming, trafficking of Golgi bodies, accumulation of hydrogen peroxide (H202) 
and papilla deposition (Bolwell and Wojtaszek 1997; von Ropenack, Parr et al. 1998). Papillae 
are collections of callose (β-1,3 glucan) that are assembled by the host acting as a physical 
barrier to penetration by the APPS peg. Interestingly it has been shown that papillae formation 
occurs irrespective of host resistance or susceptibility (Makepeace, Oxley et al. 2007). Heitfuss 
(2001) found that the chemical composition and speed of deposition of papillae plays an 
important role in the success or failure of subsequent intracellular haustorial formation.  
Successful penetration leads to the formation of haustoria by invagination of the plant plasma 
membrane. These specialised feeding structures absorb and deprive the plant of chlorophyll, 
proteins and amino acids (Dik, Carver et al. 2002). The fungal demands for host derived 
nutrients, coupled with the associated decline in host photosynthetic ability ultimately results 
in reductions in yield and grain quality. After the successful establishment of intracellular 
haustoria, elongated secondary hyphae are formed on the host epidermal leaf surface (Figure 
4). In susceptible cultivars, powdery colonies are formed on the adaxial surface of the leaf. 
Each colony is composed of both masses of mycelia and conidial chains which form from the 
conidiophore approximately 72h post infection (Boyd, Smith et al. 1995). Every successful 
infecting conidium has the potential to produce millions of asexual offspring. Each is then 
capable of spreading to other aerial parts of the plant and neighbouring hosts, where the 
infection cycle can initiate again. The asexual reproduction cycle has the potential to occur 
several times within a single season, depending on the efficacy of various control methods 
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Figure 4. The polycyclic life-cycle of Blumeria graminis f. sp. hordei. 
 
Bgh has two cycles of reproduction. The haploid asexual cycle is the predominant means 
by which powdery mildew proliferates, and the sexual cycle that allows for genetic 
recombination (a) In the asexual cycle conidia germinate and produce a series of germ 
tubes which may penetrate the epidermal cell wall of a susceptible host. Intracellular 
feeding structures known as haustoria are then produced. (b) Using plant derived 
nutrients conidia produce secondary hyphae which spread across the adaxial leaf surface. 
(c) Hyphae proliferate to form dense mats of mycelium. (d) Conidiophores from mycelia 
give rise to chains of asexual conidia. The mass of mycelium and conidial chains give the 
pathogen its fluffy powdery appearance. Conidia are dispersed by wind onto susceptible 
neighbouring barley plants where the cycle can initiate again. (f) The sexual cycle is a 
short diploid phase which may occur only once per season and is initiated by contact 
between hyphae of two different mating types. In the sexual cycle, fruiting bodies called 
cleistothecia are formed which permit the fungus to overwinter on susceptible stubble 
debris. (g) Under favourable conditions the cleistothecia burst releasing sexual progeny, 
known as ascospores, which can then initiate infection on newly planted crops in 
subsequent seasons.  
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During Bgh’s life cycle the haploid asexual form prevails except for a short diploid phase which 
after mating results in the formation of cleistothecia. These structures are robust and provide a 
way for the fungus to remain dormant on barley stubble debris between cropping seasons. 
Under optimal temperature and moisture conditions the cleistothecia can burst releasing their 
sexual progeny known as ascospores, which can then initiate infection on susceptible cultivars 
in subsequent seasons. The divergent mating system has a considerable effect on how gene 
diversity is distributed within the total Bgh population. While asexual reproduction is the 
quickest means of exponential population growth, sexual reproduction provides an added 
advantage through the generation of novel genotypes or pathotypes through genetic 
recombination. With abundant asexual spore production, a relatively short latent period 
(approximately 7-10 days) and sexual recombination, Bgh is well-equipped to swiftly adapt to 
extensively utilised control methods. 
 
 7.14 Economic impact 
Powdery mildew is one of the most common and destructive diseases of barley. Generally, 
losses are complex to estimate and depend on several factors such as climate, timing of disease 
onset, disease severity and the availability of effective control measures, all of which can vary 
greatly from one season to the next. In practice, when conditions for mildew are optimum, 
losses can reach as high as 40% (Dreiseitl and Platz 2012). Although it occurs in most if not 
all parts of the world where barley is grown, it is not considered to be a major problem in every 
region. In the UK and Europe, Bgh is controlled through coordinated uses of cultivar resistance, 
including mlo (refer to 7.2 for an explanation of mlo), and the application of fungicide when/if 
required. In Australia powdery mildew is ranked the second most destructive barley disease 
being a serious threat to production in southern cropping regions (Lord and Kehoe 2014). In 
WA, powdery mildew can be particularly devastating, where the predominance of highly 
virulent pathotypes coupled with widespread fungicide resistance has led to losses of $100M 
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 7.2 Literature Review and Discussion 
 
 7.21 Disease Management 
Australian barley growers have a world-wide reputation for producing high quality malting 
barley. Fields of barley cover much of the south-west high rainfall WA cropping area and 
powdery mildew infection has proven to be a persistent threat to production in recent years 
(GRDC 2012). Generally, Bgh is controlled in other barley growing regions of the world 
through comprehensive integrated pest management strategies. Such strategies rely on host 
resistances, the timely application of effective fungicides and a range of cultural practices 
including stubble and green bridge removal. Historically in WA the majority of the barley 
cropping area has been sown with cultivars harbouring defeated resistance genes (Paynter, Hills 
et al. 2014). Australian fungicide registrations have meant that growers in regions prone to 
infection have had to rely on cultural practices and fungicides of a single mode of action for 
barley powdery mildew control. 
 
  7.211 Cultural Practices 
Cultural disease management practices are essential components in any integrated pest 
management strategy. Cultural control practices are those undertaken by growers in an effort 
to minimise the spread, severity and onset of disease. This includes green bridge and stubble 
management (Pankhurst, McDonald et al. 2002), crop or pasture rotation (Peters, Sturz et al. 
2003), optimisation of nitrogen input (Bainbridge 1974) and other general farm hygiene 
practices. Green bridge management involves the removal of mislaid host plants which can act 
as over-summer sources of inoculum. The widely adopted practice of no-till farming in WA 
results in the retention of crop residues and stubble from one season to the next (Bockus and 
Shroyer 1998). As with many other ascomycetes, Bgh form cleistothecia which can remain 
dormant on stubble for many seasons. In optimum conditions cleistothecia burst releasing 
ascospores which can initiate infection on newly planted barley seedlings. Foliar application 
of effective fungicides and the use of robust cultivar resistance genes have proven to be the 
most efficient means of controlling Bgh (Jayasena, Beard et al. 2008). The nitrogen level 
applied to barley crops also has a significant impact on disease intensity. Correlations have 
been drawn between the increased application of nitrogen and the increase of spore density per 
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  7.212 Breeding for Resistance 
    7.2121 Host Resistance 
Both wild and cultivated plant species are constantly exposed to a plethora of pathogens. What 
determines whether a pathogen can successfully cause disease is dependent in many cases upon 
the presence and/or absence of genes in the pathogen and plant host. The different defence 
mechanisms employed by plants can be distinguished by the specificity of their action. In the 
interaction between barley and Bgh, four levels of resistance have been described; non-host 
resistance, race specific and major and minor non-race specific resistance (Jørgensen and 
Wolfe 1994). The first level of protection is non-host or basic resistance which protects against 
colonization by individual fungal species and is highly effective and durable (Thordal-
Christensen 2003) In the case of powdery mildew, non-host resistance protects barley from 
infection by other formae specialis (ff. spp.) of B. graminis such as the wheat powdery mildew 
Blumeria graminis f. sp. tritici.  This type of resistance is in contrast to race specific resistance 
which is expressed by only specific genotypes of a host plant and not the entire genus (Heath 
2000).   
A large volume of theoretical and experimental work has been conducted to elucidate the 
biological mechanisms behind such a robust form of plant innate resistance. Its appears as 
though defence responses in non-host plants are coordinated through programmed efforts 
between the formation of physical barriers to penetration (Trujillo, Troeger et al. 2004), the 
synthesis and accumulation of reactive oxygen species at attack sites (Bolwell and Wojtaszek 
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    7.21211 Race Specific Major R Gene Resistance 
There are additional defence mechanisms that act to prevent fungal colonization even when 
basic compatibility has been established and the plant is a natural host for the pathogen. Barley 
presents a second level of defence that is governed by specific interactions between genes in 
both host plant and Bgh. In 1971, Henry Flor hypothesized the ‘gene-for-gene’ interaction 
following observations on the flax rust fungus, Melampsora lini (Flor 1971). Flor postulated 
the existence of complementary genetic elements, a dominant/semi-dominant major resistance 
gene (R) in the plant and a corresponding dominant avirulence gene (Avr) in the pathogen (Flor, 
1971). If a plant resistance receptor recognises a pathogen avirulence effector (Figure 4a) a 
defence response will be activated conferring plant resistance and fungal avirulence (Caffier, 
Vallavielle-Pope et al. 1996). Conversely, the loss or alteration of either the R or Avr gene will 




Figure 5. The gene-for-gene hypothesis in biotrophic pathogens. 
 
(a) If the plant resistance gene receptor (R receptor) recognizes a corresponding fungal 
avirulence effector (Avr) host responses prevent disease. If either the corresponding 
plant R receptor (b) or the fungal Avr protein (c) are absent or non-functional, fungal 




At the species level, natural polymorphisms in R and Avr genes make it possible to discern 
plant lines and Bgh isolates, respectively. Barley has a large number of R genes for race specific 
resistance against Bgh. Jørgensen and Wolfe (1994) estimated that barley had 85 such R genes, 
located at 10 separate loci spanning several chromosomes. Landrace collections from centres 
of barley domestication mean there is a large pool of potentially resistant germplasm that could 
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be incorporated into barley breeding programs. Populations of Bgh are notorious for being 
composed of numerous races or pathotypes (Brown and Wolfe 1990; Bousset, Hovmøller et al. 
2002; Aghnoum 2009). Each pathotype is defined on the basis of the presence of Avr genes 
and hence, their differential patterns of virulence on barley cultivars (Heitefuss 2001). With 
this knowledge, collections of Bgh can be screened on cultivars with known R genes to 
elucidate which avirulence genes are present in a population and which R genes barley cultivars 
harbour. Such screens have been used worldwide (Wolfe, Brändle et al. 1992; Müller, 
McDermott et al. 1996; Dreiseitl, Dinoor et al. 2006) although prior to the work of Tucker et 
al. (2013) no such differential tests employing the Pallas lines have been performed on 
Australian Bgh isolates. Studies conducted by Chan and Boyd (1992) utilized a number of 
cultivars from WA, the United States of American and the UK to screen for Bgh virulence’s 
present in the WA population over the 1983-1984 cropping season. Cultivars containing the 
same single R  genes as those used in the study herein were used including those containing  
Ml-k, Ml-g, Mla-t, Ml-h, Ml-8, Mla-1, Mla-3, Mla-6, Mla -7, Mla-9, Mla-10, Mla-12 and  Mla-
p1. Unfortunately the cultivars used by Chan and Boyd (1992) for Bgh pathotype determination 
did not utilize an isogenic cultivar set and therefore any differences in virulence and 
susceptibility cannot entirely be attributed to the presence or absence of R genes and not from 
other cultivar characteristic or pleotropic effects.  
 
There have been surveys conducted in many barley growing regions of the European Union 
employing, among others, several of the Pallas isogenic lines. Hovmøller et al. (2000) co-
ordinated barley powdery mildew resistance surveys on a European scale from 1995-1999 in 
efforts to provide both temporal and spatial comparisons of virulence across national borders.  
The frequencies of virulence to cultivars possessing known R genes was assessed in barley 
powdery mildew populations, across thirteen geographically distinct countries. Resistance 
genes Mla-1, Mla-3, Mla-6, Mla-7, Mla-9, Mla-12, Mla-13, Ml-k and Ml-La were examined 
and changes in virulence frequency were noted from 1995 to 1999. Full data sets were 
generated for several sites including the Czech Republic, Denmark and the UK. Some genes 
such as Mla-3, Mla-9 and Ml-k were the single dominant resistance gene present in a Pallas 
isoline and as such any Bgh virulence or avirulence towards these particular isolines could be 
directly attributed to the presence of the gene. Interestingly, virulence to resistance genes Ml-k 
and Mla-9 decreased in frequency over the years surveyed in several locations, most strikingly 
virulence to the Mla-9 gene which decreased in Latvian Bgh populations from 75% in 1995 to 
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50% in 1998. In this example, the decline of virulence towards the Mla-9 gene may have been 
a direct result of concerted efforts in reducing the sowing of barley cultivars harbouring the 
Mla-9 powdery mildew resistance gene. Any reduction in selection pressure that favours a 
particular Bgh pathotype over others, will correspondingly decrease the pathotypes local 
advantage. The dramatic decrease in pathotype frequency in as little as a few cropping seasons, 
emphasizes the importance of cultivar selection. Whereby the utilisation and rotation of barley 
cultivars with effective  R genes can result in in a far more manageable Bgh population.  
Unfortunately, the efficacy of dominant R genes is usually only short-lived. Bgh has many 
characteristics that support rapid adaption and a single nucleotide polymorphism in an Avr gene 
may result in non-recognition by the host resulting in successful fungal penetration leading to 
disease (Jørgensen and Wolfe 1994). In WA, foreign demand has led to the continual and 
widespread planting of a small number of cultivars which often share the same barley powdery 
mildew R gene (Dreiseitl and Platz 2012; Paynter, Hills et al. 2014; Tucker, Lopez-Ruiz et al. 
2014). The combination of  sowing such a large monoculture with Bgh’s propensity for 
adaptation will likely result in the breakdown of major R gene efficacy, which has been shown 
to occur even in one to two seasons (Lyngkjaer, Newton et al. 2000). Consequently many of 
the current WA cultivars have some degree of susceptibility to Bgh infection (Tucker, Jayasena 
et al. 2013). This has led to far reaching spread of Bgh resulting in devastating losses.  
In addition to characterising isolates based on the presence or absence of Avr genes, 
microsatellite markers can also be valuable tools in studying genetic structure of a pathogen 
population. Microsatellites or SSRs (short sequence repeats) are short segments of genomic 
DNA composed of numerous nucleotide repeat motifs. The number of repeat motifs varies 
within the pathogen population because they are highly susceptible to slippage during DNA 
replication (Bruford and Wayne 1993). The length of SSR repeat motifs are heritable and can 
be used to establish genetic relatedness within a population. Specific SSR haplotypes can also 
be used to track or identify the origin of genetic mutations in other regions of the organism’s 
genome. Screening of populations can provide insight into whether a genetic mutation, say 
conferring fungicide resistance, has occurred within a single isolate which is then passed to 
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     7.21212 Non-Race Specific Minor Gene Resistance 
 
In addition to major R gene resistance, researchers have been aware of non-race specific 
resistance for several decades in adult cultivars with defeated major R genes (Shaner and 
Finney 1977; Jones and Davies 1985; Shtaya, Marcel et al. 2006). This type of resistance is 
usually partial, allowing for a low rate of mildew infection and a prolonged latent period with 
an associated  decrease in sporulation (Asad, Bai et al. 2014). Non-race specific resistance is 
highly variable, even between cultivars of the same plant species. Resistance mediated in this 
manner is often more durable then race-specific major gene resistance and as a consequence, 
there is increased interest in the development of breeding germplasm harbouring race non-
specific resistances. 
 
    7.21213 Non-Race Specific Durable mlo Resistance 
The presence of the dominant Mlo gene in barley is an absolute requirement for successful Bgh 
colonisation (Piffanelli, Zhou et al. 2002). Cultivars with loss-of-function alleles of mlo are 
therefore resistant to all known pathotypes of Bgh (Wolter, Hollricher et al. 1993).  Owing to 
its broad-spectrum nature, the use of mlo in barley agriculture has remained a success story for 
over 45 years (Tacconi, Baldassarre et al. 2006). In the barley-Bgh pathosystem, papilla 
formation is the predominant mechanism to arrest fungal penetration in partial non-race 
specific resistance and in complete Bgh resistance mediated by the presence of mlo.  
There have been many reports of mlo-associated negative pleiotropic effects causing reductions 
in yield compared to cultivars with functional Mlo. These include spontaneous deposition of 
papillae in unchallenged plants (Panstruga 2005), increases in susceptibility to necrotrophic 
pathogens including Cochliobolis sativus (Kumar, Hückelhoven et al. 2001) Magnaporthe 
oryzae (Jarosch, Kogel et al. 1999) and Pyrenophora teres (Brown and Rant 2013), decreases 
in symbiotic mycorrhizal colonisation (Marshall, Newton et al. 2009) as well as the onset of 
premature leaf senescence (Prell and Day 2001). Historically, Australian barley breeders have 
therefore tended to concentrate on the integration of major R genes (Dreiseitl and Platz 2012). 
European breeders have now produced elite mlo cultivars without any reported pleiotropic 
effects, with approximately 70% of spring barley cultivars now harbouring mlo (Lyngkjaer, 
Newton et al. 2000).  
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In WA, annual variety trials are conducted that test the suitability of new cultivars in each of 
the six main barley cropping regions. Recently three mlo containing varieties were examined; 
Westminster, Henley and Granger. These cultivars were bred using European spring barley 
germplasm and consistently performed better than the market leader cv. Baudin in regards to 
yield (NVT 2014). All three cultivars were resistant to Bgh and have now received malting 
accreditation (BarleyAustralia 2015). The key factor in lessening the impact of Bgh in WA is 
to reduce the area sown with susceptible cultivars. Currently many susceptible varieties are in 
high market demand and in some cases the premiums offered offset the majority of costs 
involved in controlling powdery mildew (Paynter, Hills et al. 2014). New malting cultivar 
options and those waiting accreditation will assist in decreasing the area sown to susceptible 
cultivars, although the enduring test will be gaining favour in the international market. 
 
7.2122 Historical Cultivar Use in West Australia 
Barley grain in Australia is an extremely important economic commodity, second only to 
wheat. In WA over 2.5M tonnes of grain is produced annually of which 85% is exported - 
contributing one sixth of the world’s traded malting barley (ABARES 2014). The temperate 
climate of much of the WA barley cropping area lends itself to high yields, producing grain 
with excellent malting characteristics. Barley also represents a valuable rotational crop, which 
can assist in breaking host specific leaf and root disease cycles. There are a range of barley 
cultivars available to growers each with different characteristics of yield potential, agronomic 
features, disease resistance profiles and grain quality. Australian barley cultivars certified as 
malt, feed or food grades depending on their likely use and suitability post-harvest. 
Traditionally, growers decide which to grow depending on a number of factors. These include 
(i) the end price paid for seed and the likelihood that a particular cultivar will meet the required 
grade (ii) yield potential (iii) agronomic and disease resistance characteristics under specific 
environmental conditions and (iv) varietal market demand. Usually malt grade cultivars fetch 
a premium over feed or food varieties but factors such as weather and disease pressure, which 
vary season to season, can affect profit margins. Historically in WA particular barley cultivars 
have tended to fare better than others and have become market leaders in the industry. Each of 
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 7.21221 End Price for Malt Grade Seed  
Identifying the option that will lead to the greatest net return is complex and can vary 
dramatically from one season to the next. In some instances, the premium price paid for malt 
grade seed adequately compensates for the lower yield of some varieties when compared to a 
higher yielding feed variety. In other situations, the substantially higher yield of feed varieties, 
or the low possibility of a variety being sold as malt grade grain, may justify the choice of a 
feed variety. Historical data indicates that four cultivars consistently achieve higher sale prices 
than other varieties grown in WA. These are Baudin, Hamelin, Gairdner and Stirling which 
normally attract $12.60/t more than the average paid for barley grain. Baudin, the market leader 
fetching the highest price for barley grain per tonne, is rated highly susceptible with Hamelin, 
Gairdner and Stirling rated as susceptible to Bgh infection. Growers are most likely to choose 
cultivars that pay a premium post-harvest and thus these mildew susceptible cultivars have 
occupied on average 55% of the total of the WA barley growing area for nearly the last decade 
(CBH 2014).This has gifted the pathogen perfect conditions for proliferation and hence 
adaptation, key contributing factors to the prevalence of Bgh in WA. 
     7.21222 Cultivar Yield Potential 
Another determining factor in selecting which cultivar to sow is the potential yield post-
harvest. Each cultivar has certain agronomic characteristics which when grown under particular 
environment conditions will yield on average a certain amount of grain. Growers must compare 
the predicted sale price of grain with a cultivar’s yield potential in selecting which cultivar to 
grow. Currently in WA the majority of malt grade cultivars (achieving higher end sale price 
over feed or food varieties) with the highest yield potential (Paynter, Hills et al. 2012) are 
susceptible to powdery mildew infection.      
 
7.21223 Agronomic and Disease Resistance  
      Characteristics 
Ultimately agronomic and disease resistance characteristics will determine the total input costs 
associated with growing particular varieties. A grower must match any agronomic and disease 
resistance characteristics with the local environmental conditions in an effort to try and keep 
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costs afforded by fertiliser and fungicide applications to a minimum. Many additional post-
seeding costs can be avoided by sowing cultivars that have genetic protection against local 
pests and disease (French 2003). Barley mlo cultivars can potentially be grown in WA mildew 
prone regions without the threat of yield losses from Bgh infection. A handful of mlo cultivars 
are currently undergoing field assessments for their suitability for growth in WA and early 
reports are positive (GRDC 2014). Despite this, exact quantification of the effect of mlo in 
varieties grown in WA cannot be gauged without more extensive and thorough trials. However, 
it should also be noted that the resistance profiles of the new mlo varieties are moderately 
resistant or moderately susceptible (Paynter and Hills 2011) to net type net blotch which is the 
predominant form of net blotch in WA (Lord and Kehoe 2014). Despite this mlo varieties may 
be a suitable option in reducing Bgh disease pressure and reduce the use of fungicides in 
controlling the disease. 
 
     7.21224 Market Demand 
Market Demand is perhaps the major factor in determining which cultivar a grower will select. 
If there is not foreign demand for a particular malt grade cultivar, seed will only be sold at feed 
grade, substantially dropping the price/tonne paid. New high yielding cultivars are currently 
undergoing malt accreditation many of which have increased resistance to Bgh.  
(BarleyAustralia 2014). It is imperative that any new cultivars possess similar malting 
characteristics to Baudin in efforts to persuade international buyers to replace the seed in 
production. The replacement of Bgh susceptible varieties with high grade resistant varieties 
does take time as many of the susceptible varieties are in high market demand. Unfortunately, 
in some cases the premiums offered for premium malt grade seed offsets most of the cost of 
applying fungicides to combat the Bgh infection.  
Each of the four factors that determine which cultivar growers will choose have contributed to 
the majority of WA barley cropping area being seeded with Bgh susceptible cultivars for the 
last decade (Paynter, Hills et al. 2011). This has provided conditions where Bgh can flourish 
and hence diversify and has now adapted to overcome many control methods. 
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7.213 Chemical Control 
In the absence of fully effective host resistance, fungicides become essential for the 
maintenance of healthy crops and reliable yields of high-quality produce. Records date the use 
of sulphur in controlling powdery mildew back to 1824 when a number of basic chemicals 
were used on  several important agricultural pathogens (Russell 2005). Since then many 
additional chemicals belonging to several different modes of action (MOA) have been found 
to be effective in both the eradication and protection of barley against Bgh. Despite the success 
of mlo in European agriculture, WA growers have relied upon the application of fungicides to 
control Bgh on susceptible cultivars (Tucker, Lopez-Ruiz et al. 2014). As of 2007, some 150 
different fungicidal compounds are used in worldwide agriculture (Brent and Hollomon 2007). 
Regardless, triazoles have been the sole class of fungicides available for protecting WA barley 
crops since 1995 (APVMA 2014).   
 
    
7.2131 Triazole Fungicides 
Triazole fungicides are the most widely used class of antifungal agents for the control of 
medical (Snelders, Camps et al. 2012), veterinary (Beernaert, Pasmans et al. 2009) and 
agricultural fungal pathogens (Poole and Arnaudin 2014). The chemical structure of each 
triazole compound contains a characteristic five membered heterocyclic aromatic ring, 
composed of two carbon and three nitrogen atoms having (Figure 6). The 1,2,4 triazole isomer 
forms the backbone of many antifungal compounds with significant agricultural and medicinal 
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Figure 6. The 1,2,4 triazole  isomer. 
 
The 1,2,4 triazole isomer forms the chemical backbone for the most widely used group 
of antifungals in agriculture. Figure used with permission from ChemSpider. 
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Triazoles have a single-site MOA targeting the product of the Cyp51 gene, the enzyme 
cytochrome P450 14α-demethylase. In fungi Cyp51 has been shown to catalyse the C14-
demethylation of a collection of structurally similar substrates including lanosterol and 
obtusifoliol (Lepesheva and Waterman 2004). The action of cytochrome P450 14α-
demethylase has been well studied in most fungi where it catalyses the demethylation of 
lanosterol in the biosynthesis of ergosterol, an essential membrane sterol (Lepesheva and 
Waterman 2007; Weete, Abril et al. 2010). However, the role of cytochrome P450 14α-
demethylase is less well characterised in a number of powdery mildew fungal species including 
Blumeria graminis. It has only been as recent as the last decade that studies by Weete et al. 
(2010) and Lepesheva and Waterman (2007) have examined the alternate action of Cyp51 in a 
handful of Blumeria spp. In these fungi, sterol biosynthesis takes an altered pathway compared 
to that in yeast and other filamentous fungi. Here, lanosterol is first converted to 24-
methylenelanosterol, which becomes the preferred substrate for C14-demethylation by Cyp51 
(Figure 7). A cascade of further enzymatic reactions then results in the production of the key 
membrane sterol in Blumeria spp., 24-methylcholesterol (Weete, Abril et al. 2010). In other 
filamentous fungi and yeast spp. Cyp51 acts directly upon lanosterol, resulting in the 
production of zymosterol and eventually leading to the synthesis of ergosterol (Weete, Abril et 
al. 2010). For many years the main dogma of thought incorrectly assumed that the main sterol 
in the cellular membrane of all fungal species was ergosterol (Fuchs, Vries et al. ; Elewski 
1993; Dupont, Lemetais et al. 2012). With the comparatively recent characterisation of 24-
methycholesterol in Blumeria spp. further investigations into the membrane sterol content of 
additional filamentous fungal species may lead to the identification of additional, perhaps novel 
Cyp51 substrates. What is common to all species studied thus far is that Cyp51 plays a pivotal 
role in formation of key sterols in plant, mammal and fungal species. Membrane sterols are 
essential in maintaining optimum cellular function and integrity and as such their biosynthesis 
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Figure 7. The sterol biosynthesis pathway in in filamentous fungi.  
The Cyp51 enzyme catalyses a three-step C14 demethylation (Waterman and Lepesheva 2005) 
in the cascade of reactions converting 24-methylenelanosterol to fecosterol in the synthesis of 
24-methyl-cholesterol in Blumeria spp. (pathway indicated in red) and the conversion of 
lanosterol to zymosterol in the synthesis of ergosterol in other filamentous fungi (indicated in 
blue). Adapted from Weete et al. (2010).  
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In addition to Cyp51, other key enzymes involved in sterol biosynthesis have also become 
targets for other groups of antifungals. All fungicides targeting sterol biosynthesis are referred 
to collectively as sterol biosynthesis inhibitors (SBIs). This class of fungicide, encompassing 
the DMI group, is further categorised into four subclasses depending upon the enzymatic target 
(Figure 8). Amine fungicides, including the morpholines and spiro-ketalamines such as 
spiroxamine (recently granted a provisional permit for use in WA (APVMA 2014)), inhibit the 
biosynthesis of sterols by targeting two genes - Erg24 encoding C14-reductase and Erg2 
encoding C8-isomerase. This group, comprised of seven compounds to date, has a limited 
spectrum of disease control compared to triazoles, although is particularly effective against the 
powdery mildews (Oliver and Hewitt 2014). The third class of DMIs are the hydroxyanilides. 
Hydroxyanilides also act on a key enzyme in sterol biosynthesis, coded for by the Erg27 gene 
(Fillinger, Leroux et al. 2008). As yet only a single hydroxyanilide compound has been 
described, fenhexamid, which although has good activity on Botrytis cinerea, has only limited 
activity on other ascomycete pathogens (Oliver and Hewitt 2014). Therefore fenhexamid has 
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Figure 8. Classes of fungicides inhibiting membrane sterol biosynthesis (SBI). 
G1-4 represent the sub-classifications as defined by the Fungicide Resistance Action 
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      7.2132 Mode of Action 
 
In silico structural modelling is now increasing being used to assess decreases in triazole 
susceptibility due to conformational changes in Cyp51 (Bowyer and Denning 2014; Hoekstra, 
Garvey et al. 2014).  Such investigations have primarily focused on differences in the binding 
of triazoles to both the wild-type and mutant Cyp51 protein variants.  (Parker, Warrilow et al. 
2014). Ideally, triazole docking studies should be performed with the Cyp51 protein from the 
species of interest following x-ray crystallisation. However, this is not always possible, given 
the membrane bound nature of many Cyp51 enzymes present in filamentous fungi. As an 
alternate means, many in silico triazole docking studies have been performed by amalgamating 
known structures of a pool of crystallised Cyp51 enzymes to produce a likely Cyp51 model for 
the species of interest. One of the most extensively studied Cyp enzymes is Cyp101 from 
Pseudomonas putida, being first described by Poulos et al. (1985). The crystallisation of 
additional Cyp enzymes since this time has led to the identification of characteristic protein 
folds that have thus far been shown in all Cyp enzymes (Hasemann, Kurumbail et al. 1995).  In 
general 13 α-helices (A, B, B` and C-L) and 5 β-sheets (β1-β5) have been shown to contribute 










Figure 9. Ribbon diagram showing the overall fold and secondary structure of a Cyp 
enzyme from Pseudomonas putida (P450cam). 
 
The secondary structure shows 13 α-helices (A, B, B` and C-L) and 5 β-sheets (β1-β5) 
forming the characteristic P450 fold found to be common to all Cyp enzymes crystallised 




36 | P a g e  
 
Cyp51 produced sterol 14α-demethylase is one of the most widely distributed P450s enzymes, 
with orthologues having been identified across all biological kingdoms (Lepesheva and 
Waterman 2004). Although the biological function of Cyp51 is well conserved, the encoding 
target gene sequence can vary between kingdoms. On average, sequence identity is 
approximately 30%, but ranges from high (95%) in closely related species such as mammals 
to much lower (23%) when surveyed across all kingdoms (Lepesheva and Waterman 2007). In 
fungi, Cyp51 sequence identity ranges from 45% between yeasts and filamentous fungi 
(Candida glabrata and Aspergillus nidulans) to 65% within filamentous fungal pathogens 
(Aspergillus fumigatus and Penicillum digitatum) (Lepesheva and Waterman 2011). Studies by 
Gotoh (1992) first identified several regions retaining a high degree of homology even over 
diverse kingdoms. Five putative substrate recognition sites (SRS) were hypothesized based on 
group-to-group alignment of eukaryotic Cyp51 sequences to a previously crystallised bacterial 
sequence of Pseudomonas putida. Most of these SRS were confirmed with the crystallisation 
of  Cyp51 from Mycobacterium tuberculosis by Podust et al. (2001) and can be mapped over 
plant, fungal and bacterial species (Figure 10). Triazole antifungals have been shown to interact 
with the SRS of Cyp51 in a number of fungal species (Yoshida and Aoyama 1991). 
Mutagenesis studies targeting select amino acids have correlated changes in SRS regions with 
decreases in triazole susceptibility (Cools, Parker et al. 2010), indicating the significance of the 
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Figure 10. Sequence alignment of Cyp51 proteins from animal, bacterial and fungal 
species. 
Mutations discussed in this thesis are indicated with red boxes. Species include Blumeria 
graminis f. sp. hordei (Bgh m), Zymoseptoria tritici (M. gram), Aspergillus fumigatus (A. 
fum), Trypanosoma brucei (T. bru), Homo sapiens (Homo), Candida albicans (C. alb) and 
Saccharomyces cerevisiae (S.cer). Numbers refer to amino acid positions in Bgh. Amino 
acids conserved are shaded in black (100% homology), dark grey (83% homology), and 
light grey (66% homology). Substrate recognition sites (SRS) are shown in blue with the 
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Unfortunately, triazole resistance is now common in both the clinical (Denning, Park et al. 
2011) and agricultural sectors (Cools, Fraaije et al. 2006) including powdery mildew 
populations from other barley growing regions of the world (Wyand and Brown 2005). The 
similarity in the structure of triazoles coupled with the specificity of the compounds mode of 
action, raises the issue of cross resistance, whereby a mutational change conferring insensitivity 
to one triazole may confer insensitivity to others. Cross resistance to a number of triazoles has 
been confirmed in several important fungal crop pathogens (Robbertse, Van Der Rijst et al. 
2001; Cools and Fraaije 2008). Given that prior to 2012, all registered fungicides for barley 
powdery mildew control in WA contained a fungicide from the triazole class (APVMA 2014), 
the likelihood of detecting resistance in this pathogen population seems almost inevitable. 
 
   7.2133 Mechanisms of Fungicide Resistance.  
Fungicide resistance is conferred through stable, heritable genetic mutations (Gisi, Waldner et 
al. 2007). Reductions in sensitivity appear in agricultural or clinical settings as the frequency 
of the mutation increases in the pathogen population (Ma and Michailides 2005). The 
breakdown of effective fungicidal activity via the increase of resistance in a pathogen 
population is thought to evolve through two distinct phases – genetic mutation followed by 
selection (Hobbelen, Paveley et al. 2014). An important point to note in the evolution of 
resistance is that genetic mutations occur randomly throughout an organism’s genome and it is 
purely by chance that such a change will confer fungicide resistance. Thus it is theoretically 
possible that resistance mutations could  be detected in fields that have previously been devoid 
of fungicides (Gisi, Chin et al. 2000). For fungicide breakdown to occur, an external agent must 
provide a mutant individual a selective advantage over the majority of the wild-type population. 
Under these conditions, resistant mutants will be selected and can then proliferate to become 
the dominant form in the pathogen population eventually leading to fungicide resistance (van 
den Bosch, Oliver et al. 2014). 
Devoid of selection, mutations conferring fungicide resistance will only persist in pathogen 
populations in the absence of associated fitness costs. B. cinerea shares many of the same 
characteristics of Blumeria spp. meaning that adaptations encoding fungicide resistance can be 
very common in natural field and vineyard populations.  Both Billard et al.(2012) and Veloukas 
(2013) examined the impact that mutations conferring fungicide have impacted on the survival 
capability of B. cinerea isolates. Resistance to the SBI fungicide fenhexamid, has been shown 
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to be conveyed by mutations in the Erg27 gene, with the highest levels of  resistance reported 
in field isolates harbouring one of  F412S/I/V changes (Fillinger, Leroux et al. 2008). 
Surprisingly despite the repeated and prolonged period of application, fenhexamid has 
remained effective in the controlling B. cinerea despite the dominance of the F412 mutant 
genotype in French vineyards (Billard, Fillinger et al. 2012). Isogenic fenhexamid resistant 
strains of B. cinerea were generated, each carrying one of the naturally occurring F412 
mutations to assess the effect that each change had on overall phenotype.  Billard et al. (2012) 
found that there was a moderate but significant impact of Erg27 F412 mutations on isolate 
survivability in vitro which may account for the continued effectiveness of fenhexamid despite 
the high frequency of resistance in the natural population.  
Dual resistance to both succinate dehydrogenase inhibiting (SDHI) and quinone outside 
inhibiting (QoI) fungicides is now a common trait in many B. cinerea populations around the 
world (Bardas, Veloukas et al. 2010; Fernández-Ortuño, Chen et al. 2012; Amiri, Heath et al. 
2013). Resistance to SDHI has been shown to be conveyed through mutations in SdhB, SdhC 
and/or SdhD genes (Bardas, Veloukas et al. 2010). The G143A substitution is the main 
mutation shown to be associated with QoI resistance (Ishii, Yano et al. 2007). Veloukas et al. 
(2014) assessed the impact that the G143A CytB mutation had on B. cinerea field isolates and 
in addition the fitness costs associated with the acquisition of additional Sdh mutations. The 
fitness costs associated with the presence of the CytB mutation have been reported as having 
variable effects on fitness. Ma and Uddin (2009) reported a select fitness advantage of wild 
type strains of Magnaporthe oryzae compared to CytB mutants, while in Alternaria alternata 
isolates did not exhibit any in vitro associated fitness costs that could be pertained to the 
presence of the G143A mutation (Karaoglanidis, Luo et al. 2010).For B. cinerea, the G143A 
CytB substitution does not exhibit any associated fitness costs (Veloukas, Kalogeropoulou et 
al. 2013). However, Veloukas et al. (2014) did observe that isolates carrying mutations in both 
CytB and Sdh genes decreased in frequency compared to wild-type B. cinerea isolates under 
fungicide selection. The fitness costs associated with the combination of mutations in B. 
cinerea, presents an opportunity to coordinate spray regimes that alternate SDHI applications 
with other MOA chemicals to delay or reduce the selection of SDHI resistance in the local 
population.   
The identification and tracking of mutations throughout SSR haplotypes can be a useful means 
in determining the place of origin and spread of fungicide resistance within a pathogen 
population. If a resistance mutation is shown to be present only in very similar haplotypes, it 
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is quite possible that resistance is a result of a single mutational event that has been selected by 
fungicide use and then passed down through generations. However, if resistance is detected in 
a diverse range of SSR haplotypes, it is more likely that same genetic mutation occurred on 
multiple occasions and was subsequently selected for by temporally distinct fungicide 
applications. At this stage, the work performed by Tucker et al. (2014) indicates that the Bgh 
resistance mutations are found in numerous diverse SSR haplotypes possibly indicating 
multiple mutational and selection events. However, further investigations employing more SSR 
markers on many more Bgh isolates are required for this hypothesis to be conclusive. 
Various molecular mechanisms have been shown to contribute to decreases in fungicide 
sensitivity (Figure 11), including alterations in target site (Cools, Mullins et al. 2011; Tucker, 
Lopez-Ruiz et al. 2015), changes in membrane composition (Löffler, Einsele et al. 2000) and 
increased active efflux (Da Silva Ferreira, Colombo et al. 2005). Unfortunately given Bgh’s 
propensity for adaptation, fungicide resistant populations are now widely reported in Europe 










Figure 11. Resistance mechanisms to triazole fungicides.  
In the absence if resistance, triazole antifungals (filled octagon) are taken up into the 
fungal cell and bind with Cyp51. Resistance to triazole fungicides has been shown to be 
conveyed by several defined mechanisms. The major mechanisms include 1) accelerated 
efflux out of the fungal cell the up-regulation of multidrug efflux transporter genes or 
duplication of ABC and MFS transporters; 2) through modification of the Cyp51 substrate, 
via amino acid substitutions in the coding sequence or changes in promoter; 3) a 
reduction in the uptake of triazole into the fungal cell through changes in membrane 
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 7.21321 Decreased Membrane Permeability and 
Changes in Cell-Wall Composition. 
Changes in membrane composition have been found to limit the accumulation of intracellular 
antifungals. For example, Stergiopoulos et al.(2003) demonstrated that altered glycosylation 
of Candida. albicans surface proteins conferred some degree of resistance to triazole 
fungicides. In C. albicans the major phospholipids of the plasma membrane are 
phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and phosphatidylserine. 
Löffler et al. (2000) found that the concentrations of phosphatidylcholine and  
phosphatidylethanolamine increased in triazole sensitive isolates whilst phosphatidylinositol 
and phosphatidylserine were increased in fungicide resistant C. albicans. Increases in the 
concentration of phospholipids in resistant isolates also brings about an increase in net negative 
charge (Löffler, Einsele et al. 2000). Löffler et al. (2000) postulated that changes in the 
composition of cell membrane phospholipids accompanied with a decrease in ergosterol 
concentration were key factors leading to a decrease in the accumulation of intracellular 
fungicides in C. albicans resistant isolates. In addition Sanglard et al. (1998) have shown that 
changes in cell wall protein characteristics also affects triazole diffusion. Mutant isolates of C. 
albicans have been shown to acquire some degree of resistance through altered glycosylation 
of cell surface proteins (Sanglard 2002). As yet no such alterations in membrane permeability 
have been reported in fungal crop pathogens including Bgh. 
 
 7.21322 Target Site Alteration 
Perhaps the most widely reported mechanisms conferring reductions in triazole sensitivity are 
mutational changes in the triazole target protein, Cyp51. Most of the substitutions are present 
in highly conserved regions across the fungal kingdom which suggests the importance of these 
residues in the maintenance of Cyp51 function throughout evolution (Figure 12). According to 
the molecular modelling of C. albicans in particular, these regions correspond to important 
functional domains of sterol C14α-demethylase and its interaction with the heme moiety, active 
site and an additional region postulated to play a role in the entry of the substrate into the 
binding pocket (Xiao, Madison et al. 2004). 
A single nucleotide polymorphism or SNP is a variation in an organism’s DNA sequence which 
results in a single base change. Nucleotide deletions, insertions or substitutions can each have 
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varying effects depending on where they occur and whether they have a corresponding impact 
on the translated protein. SNP’s within both inter and intragenic regions are likely to have 
minimal or no effect on overall fitness. Point mutations that occur within the coding region or 
exon may have no effect if the corresponding SNP does not result in an amino acid change 
(synonymous mutation). If the SNP results in the replacement of an amino acid by another 
(non-synonymous mutation) it may result in a non-functional protein or alter its molecular and 
or biochemical characteristics. Studies by Délye et al (1998) examined homology between 
fungal, animal and plant kingdoms and identified two distinct Cyp51 alleles in Blumeria: a 
DMI sensitive and a DMI insensitive. A SNP at amino acid position 136 was shown to 
distinguish between the two. The amino acid at position 136 is located within the highly 
conserved CR2 domain of all kingdoms and is thought to have a role in substrate binding 
(Délye, Bousset et al. 1998). Further studies by Wyand and Brown (2005) have characterised 
an additional SNP in the Cyp51 gene which confers DMI insensitivity. In both cases the 
substitution of a single base pair results in the alteration of the translated protein: namely the 
exchange of a tyrosine for a phenylalanine at amino acid position 136, Y136F (Délye, Bousset 
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Calbicans      MAIVETVIDGINYFL-----SLSVTQQISILLGVPFVYNLVWQYLYSLRKDRAPLVFYWI 
Ztritici       MGLLQEVLAQFDAQFGQTSLWKLVGLGFLAFSTLAILLNVLSQLLFRGKLSDPPLVFHWV 
Bghordei       MGISESFMFPYLQPLLQLGFGIALASGIISLLLLLTFLNVLKQLLFKN-PNEPPIVFHWI 
Bcinerea       MGILEAVTGPLAQEISQRSTGVVIAAGVAAFIVLSVVLNVLNQVLFAN-PNEPPMVFHWL 
                            **   *    *             *  *   *   **   **   * 
 
Calbicans      PWFGSAASYGQQPYEFFESCRQKYGDVFSFMLLGKIMTVYLGPKGHEFVFNAKLSDVSAE 
Ztritici       PFIGSTITYGIDPYKFFFSCREKYGDVFTFILLGKKTTVCLGTKGNDFILNGKLKDVNAE 
Bghordei       PIIGSTISYGMNPYKFFHESQAKYGNIFTFILLGKKTTVYLGRQGNNFILNGKLRDVNAE 
Bcinerea       PVIGSTITYGMDPYKFFFDCRAKYGDIFTFVLLGKKTTVYLGRKGNDFILNGKLKDLNAE 
                *   *          *      * * *      *        ****  * ** *   *  
 
Calbicans      DAYKHLTTPVFGKGVIYDCPNSRLMEQKKFAKFALTTDSFKRYVPKIREEILNYFVTDES 
Ztritici       EIYSPLTTPVFGKDVVYDCPNSKLMEQKKFVKYGLTTSALQSYVTLIAAETRQFFDRNNP 
Bghordei       EIYTVLTTPVFGTDVVYDCPNSKLMEQQKFMKAALTTEAFRSYVPIIQNEVKSFIEKCD- 
Bcinerea       EIYTVLTTPVFGKDVVYDCPNAKLMEQKKFMKIGLSTEAFRSYVPIIQMEVENFMKRSS- 
               * **      * *****   * * *  * * * *   *   * * * * *       * * 
 
Calbicans      FKLKEKTHGVANVMKTQPEITIFTASRSLFGDEMRRIFDRSFAQLYSDLDKGFTPINFVF 
Ztritici       HKKFASTSGTIDLPPALAELTIYTASRSLQGKEVREGFDSSFADLYHYLDMGFTPINFML 
Bghordei       --DFRKSKGIINIDAVMAEITIYTASHTLQGKEVRDRFDSSLAVLYHDLDMGFTPINFML 
Bcinerea       --AFKGPKGTADIGPAMAEITIYTASHTLQGKEVRDRFDTSFASLYHDLDMGFSPINFML 
                      *               * * * *               *   *   ** 
 
Calbicans      PNLPLPHYWRRDAAQKKISATYMKEIKLRRDRGDIDPNRDLIDSLLIHSTYKDGVKMTDQ 
Ztritici       PWAPLPQNRRRDYAQKKMSETYMSIIQKRRESKT-GEHEEDMIHNLMQCKYKDGNAIPDK 
Bghordei       HWAPLPHNRARDHAQRTVAKIYMEIINSRRTQKETDDSNLDIMWQLMRSSYKDGTPVPDK 
Bcinerea       HWAPLPHNRARDHAQRTVAKTYMDIIQNRRAQATEAEFKSDIMWQLMRSSYKDGTPVPDK 
                *      *        *   *        **      * * ***  *   *      *        
 
Calbicans      EIANLLIGILMGGQHTSASTSAWFLLHLGEKPHLQDVIYQEVVELLKE-KGGDLNDLTYE 
Ztritici       EIAHMMIALLMAGQHSSSATESWITLRLASRPDIQDELLQEQKDMLGVNADGSIKELTYA 
Bghordei       EMAHMMIALLMAGQHSSSSSSTWIMLWLAAGPDITEELYQEQLELLGSE----LPPLKYE 
Bcinerea       EIANMMIALLMAGQHSSSSSISWIMLRLASRPDIMEELYQEQIQVLGAD----LPALKYE 
                ***   **  ** *    *   * *    *       *       *  * 
 
Calbicans      DLQKLPSVNNTIKETLRMHMPLHSIFRKVTNPLRIPETNYIVPKGHYVLVSPGYAHTSER 
Ztritici       NLSKLTLLNQVVKETLRIHAPIHSILRKVKSPMPIEGTAYVIPTTHTLLAAPGTTSRMDE 
Bghordei       DLSKLSLHQNVLKEVLRLHAPIHSILRKVKNPMPVPGTSYVIPKTHSLLAAPGWTSRDAS 
Bcinerea       DLSKLPLHQNVLKETLRLHTPIHSIMRKVTTPMPISGTKYVIPTSHTLMASPGCTSRDDE 
                    *     *      ****   **    *    *      * *   ** * 
 
Calbicans      YFDNPEDFDPTRWDTAAAKANS-------VSFNSSDEVDYGFGKVSKGVSSPYLPFGGGR 
Ztritici       HFPDCLHWEPHRWDESPSEKYKHLSPTTALGSIAEEKEDYGYGLVSKGAASPYLPFGAGR 
Bghordei       YFPNPLKWDPHRWDTGSGGVI--------GTDMEDEKFDYGYGLISTGAASPYLPFGAGR 
Bcinerea       FFPEALEWDPHRWDLGSGRVV--------GNDQDEEFQDYGYGMISKGASSPYLPFGAGR 
                     *    *                 * ** **  ***** *   *   *   ** * 
 
Calbicans      HRCIGEQFAYVQLGTILTTFVYNLRWT-IDG-YKVPDPDYSSMVVLPTEPAEIIWEKRET 
Ztritici       HRCIGEQFAYVQLQTITATMVRDFKFYNVDGSDNVVGTDYSSLFSRPLSPAVVKWERREE 
Bghordei       HRCIGEQFATVQLVTIMATMVRSFKFHNLDGRNSVAETDYSSMFTRPMAPATIAWEKRDK 
Bcinerea       HRCIGEQFATVQLVTIMATVVRLFKFKNIDGSKDVIGTDYASLFTRPLAPAVVAWERR-- 
               *  *  *   * *     ***  **  *  *  *   **   * *  *      ** 
 
Calbicans      CMF--- 
Ztritici       KEEKN- 
Bghordei       KDKTEC 
Bcinerea       ------ 
 
Figure 12. Cyp51 protein alignment. 
 
Cyp51 protein sequences of Candida albicans (Calbicans, Accession: AAF00597.1), 
Zymoseptoria tritici (Ztritici, Accession: AAU43734.1), Blumeria graminis f. sp. hordei 
(Bghordei, Accession: AIO08289) and Botrytis cinerea (Bcinerea, Accession: 
CCD54835.1). Asterisks indicate known mutations in one or more of the fungal species 
listed. Amino acids common to all included species are indicated in bold for C. albicans 
(Löffler, Kelly et al. 1997; Sanglard, Ischer et al. 1998; Sanglard and Odds 2002) Z. tritici 
(Cools and Fraaije 2013), B. g. hordei (Wyand and Brown 2005; Tucker 2015 
unpublished) and B. cinerea (Albertini, Thebaud et al. 2002) 
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7.21323 Increased Target Gene Expression  
A major mechanism for increasing fungal Cyp51 expression is the presence of single insertions 
of tandem repeated sequences in the Cyp51 promoter region. This mechanism causing  
resistance to a number of triazole fungicides has been observed in isolates of the 
phytopathogenic fungi Penicillium digitatum (Hamamoto, Hasegawa et al. 2000), Blumeriella 
jaapii (Ma, Proffer et al. 2006) and Venturia inaequalis (Schnabel and Jones 2001). Here, 
resistance was correlated with the presence of tandem repeats in the promoter region of Cyp51 
leading to enhanced target gene transcription.  Transformation of a mutant Cyp51 gene, which 
included the altered promoter region, rendered sensitive P. digitatum isolates resistant and 
increased Cyp51 expression akin to levels found in resistant isolates (Hamamoto, Hasegawa et 
al. 2000). However, the extent to which this mechanism contributes to overall resistance is 
difficult to discern as increases in Cyp51 expression was not always found in V. inaequalis 
resistant isolates harbouring identical promoter insertions (Schnabel and Jones 2001).  
 
  
 7.21324 Increased Active Efflux 
ATP-binding cassettes (ABC) and major facilitator superfamily (MFS) transporters are 
membrane bound proteins present in all living organisms. These transporters  secrete a large 
number of structurally and functionally distinct compounds into the extracellular matrix 
(Figure 8), thereby preventing intracellular accumulation (Stergiopoulos, Zwiers et al. 2003). 
Due to their indiscriminate rejection of cytotoxic moieties, the accumulation of many ABC or 
MFS membrane proteins in a single isolate results in resistance across many classes of 
fungicide; i.e. being multi-drug resistant (MDR). In phytopathogenic fungi the over-production 
of transporter proteins in MDR individuals may in part be due to up regulation of genes 
encoding ABC and MFS genes. In S. cerevisiae, Sanglard et al. (1996) identified several point 
mutations in loci concerned in transcriptional regulation which were correlated with a MDR 
phenotype. In clinical isolates of C. albicans,  Sanglard and Odds (2002) reported a striking 
difference between the ABC and MFS transporters. It was found that ABC transporters can 
accept almost the entire class of triazoles used in medicine as substrates, whilst MFS 
transporters only accept fluconazole as a substrate. Such investigations into the use of 
increasing efflux as a mechanism of fungicide resistance have yet to be investigated in Bgh  but 
have been reported in field isolates of Z. tritici (Leroux and Walker 2011).  
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   8.0 Objectives 
Usually, Bgh can be controlled through planting of resistant varieties (including those 
harbouring the mlo gene) and through the application of effective fungicides. However, 
incidences of fungicide and resistant cultivar breakdown have long been reported in other 
agriculturally important mildew prone areas of the world. History has shown that the wide scale 
planting of cultivars with dominant R genes and the continual use of fungicides with a single 
MOA, can lead the build-up Bgh isolates capable of overcoming such control measures. 
Despite this foreknowledge,  barley growers in WA are now faced with an epidemic of highly 
virulent (Tucker, Jayasena et al. 2013) and fungicide resistant powdery mildew (Tucker, 
Lopez-Ruiz et al. 2015). The aim of the present study was to gain insight into the population 
of Bgh isolates by:  
1. Determining the virulence genes present in a collection of WA Bgh isolates. 
2. Analysing the population structure of Bgh isolates in West Australia. 
3. Assessing the sensitivity levels of Australian isolates of Bgh to the currently 
registered triazole fungicides available for powdery mildew control in WA. 
4. Isolating and characterising the sterol C14-α demethylase gene (Cyp51) from 
Australian isolates of Bgh differing in sensitivity to currently registered triazole 
fungicides. 
5. Analysing the role that mutations in Bgh Cyp51 play in resistance to triazole 
fungicides. 
6. Understanding the structural implications that Cyp51 mutations have on protein 
configurations and binding with triazole fungicides. 
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Initial experiments, including the curation of pathotypes, were initiated prior to 
candidature. However confirmation of results, all data analysis, preparation of the 
manuscript and submission were completed during the PhD.  
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1.1 Abstract 
The risk of fungicide resistance is greatest with pathogens with short dormant periods, with 
both sexual and asexual reproduction cycles, with large population sizes and when fungicides 
of a single mode of action (MOA) are repeatedly used. Most of the barley growing area in the 
west of Australia (WA) has been seeded with powdery mildew- (Blumeria graminis f. sp. 
hordei (Bgh)) susceptible cultivars for the last 10-15 years. Fungicides from the triazole 
group dominate the market and are used repeatedly as both seed and foliar treatments. Field 
failures have been observed leading to losses estimated at AU$100m annually since 2007. 
Reduced efficacy has often been found to result from alterations in the gene encoding triazole 
target 14α-sterol demethylase (CYP51 syn. ERG11). Clear associations were found between 
accumulations of CYP51 mutations and reductions in triazole sensitivity. The combination of 
susceptible cultivars, conducive environmental conditions and the repeated use of a single 
MOA has lead with disappointing predictability to perhaps the most costly fungicide 
resistance epidemic in history. 
1.2 Introduction 
Powdery mildew is a common fungal disease of many crops (Eichmann and Hückelhoven 
2008). In grasses, the disease caused by Blumeria (syn. Erysiphe) graminis is divided into 
formae speciales (f. sp.) each colonizing individual genera of the grass family. Blumeria 
graminis f. sp. hordei (Bgh) is the causal agent of powdery mildew of barley, Hordeum 
vulgare (Pedersen, Rasmussen et al. 2002). Barley powdery mildew (BPM) is one of the most 
damaging diseases of barley throughout the world, with the potential to cause considerable 
yield losses (Jørgensen 1992; Tacconi, Baldassarre et al. 2006). Bgh can infect all green 
tissue of the host plant and is characterised by white fluffy pustules. In acute disease 
outbreaks, these pustules tend to coalesce, so that a severely infected barley crop may appear 
yellow at a distance.  
Germplasm exploited in European spring cultivars provides complete protection against BPM 
infection. The MLO protein negatively regulates plant defences against powdery mildew, so 
cultivars carrying mlo alleles are resistant against all pathotypes of Bgh. The use of mlo in 
spring cultivars has remained a success story in agriculture for nearly 40 years (Kim, 
Panstruga et al. 2002). However, there are reported downsides to the use of mlo (Bjørnstad 
and Aastveit 1990). Cultivars with some mlo alleles are reported to have enhanced 
susceptibility to other fungal pathogens (Kumar, Hückelhoven et al. 2001) and it is claimed 
that mlo cultivars exhibit a yield penalty even in the absence of any infection (McGrann, 
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Stavrinides et al. 2014). It is for these reasons that breeders have been reluctant to include 
mlo germplasm in Australian barley breeding programs (Dreiseitl and Platz 2012). 
Breeders in WA have historically focussed on malt quality and many cultivars released over 
the last few decades have been susceptible to BPM. Therefore, growers in regions prone to 
infection have relied heavily on the application of fungicides for disease control. Triazole 
fungicides are the most widely used class of antifungal agents for the control of fungal 
diseases of humans, animals (Chamilos and Kontoyiannis 2005) and plants (Poole and 
Arnaudin 2014). This fungicide class dominates those registered for barley diseases in WA, 
being contained in all registered foliar formulations until 2013 (Table 1). Triazole resistance 
is now widely reported in both clinical and agricultural sectors including powdery mildew 
populations from other barley growing regions of the world (Wyand and Brown 2005). The 
use of formulations containing only one class of fungicide coupled with the popularity of 
BPM susceptible cultivars was a perfect recipe for fungicide resistance.  Growers in WA are 
now faced with an epidemic of highly virulent (Tucker, Jayasena et al. 2013) and fungicide-
resistant BPM (Tucker, Lopez-Ruiz et al. 2015). Here we discuss the etiology which has led 
to such an epidemic and discuss future prospects for the billion dollar barley industry in 
Australia. 
2.2 Historical cultivar use in west Australia 
Australian barley growers have a world-wide reputation for producing a reliable supply of 
high quality malting barley. Annually, WA produces on average 2.5 million tonnes of barley 
grain (ABARES 2014) of which the majority is exported for malting, shochu production, 
human consumption and animal feed (Paynter, Hills et al. 2012). The Wheat Belt is the 
common name applied to the arable area of WA, and typically has 4Mha of wheat, 1.5Mha of 
barley and 1.5Mha of other crops (mainly canola and lupins). Barley production covers much 
of the Wheat Belt  and powdery mildew infection has proven to be a massive threat to 
production in recent years (GRDC 2012). Field surveys and crop reports have mapped the 
pathogen’s spread over the cereal cropping area with extremely high levels of disease 
pressure particularly in the cooler, high rainfall areas along the south coast (Figure 1).  
There are a range of barley cultivars available to growers, each with different characteristics 
of yield potential, agronomic features, disease resistance profiles and grain quality and are 
marketed as malt, feed or food grades depending on their intended use post-harvest. Growers 
decide which cultivar to grow depending on a number of factors including (i) the end price 
paid for grain (ii) and the likelihood that a particular cultivar will meet the required grade (iii) 
likely yield potential and (iv) agronomic and disease resistance characteristics. Deliveries that 
meet malt grade specifications receive a premium price which normally outweighs the lower 
yield achievable compared to feed or food cultivars. Factors such as weather and disease 
pressure, which vary season to season, can result in downgrading of malt cultivars. 
Malt grade deliveries of cultivars Baudin, Hamelin, Gairdner and Stirling attract about 
AU$37/t more than food or feed grades (DailyGrain 2014). The market leader for export 
malt, Baudin, is highly susceptible to powdery mildew (Paynter, Hills et al. 2012) as it 
possesses only the Ml-a8 resistance gene which has now been completely defeated by Bgh in 
WA (Tucker, Jayasena et al. 2013). The three other cultivars of high popularity harbour the 
same resistance gene and are thus susceptible (Table 2). 
On a typical farm of 4500ha where 67% is cropped (Rowe 2012) growers will earn an extra 
AU$300,000 year if their deliveries achieve malt grade (based on the average yield of 
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2.91t/ha (NVT 2014)). The mildew susceptible cultivars have occupied on average 95% of 
the total barley growing area for most of the last decade (Figure 2, (CBH 2014)). This has 
gifted the pathogen perfect conditions for proliferation and hence adaptation, key contributing 
factors to the current BPM epidemic.  
Recently three mlo cultivars have been examined in WA. These cultivars, Westminster, 
Henley and Granger,  which were bred using European spring barley germplasm, consistently 
performed better than the market leader Baudin in regards to yield (NVT 2014). All three 
were resistant to BPM infection but have so far not yet obtained malt certification. The effect 
of mlo on other pathogens and yields in WA conditions clearly needs further study. New high 
yielding cultivars which have increased resistance to BPM infection are currently undergoing 
malt accreditation (BarleyAustralia 2014). If accepted, we can expect that they will replace 
Baudin and the other susceptible cultivars as long as they possess a full suite of desirable 
characteristics.  
2.3 Fungicide use in west Australia 
 2.3.1 Triazole use and the outbreak of resistance 
Fungicide use in Australian broad acre cropping has risen sharply over the last decade. 
According to a ten year review published by Murray and Brennan (2010), nearly 95% of the 
land sown to barley in mildew-prone areas of WA received some form of fungicide 
treatment, with greater than 35% having multiple applications each season. The registration 
and use of formulations is tightly controlled by Australian government bodies and product 
labels specify the crop, specific diseases and the permitted minimum and maximum doses. 
Although there are numerous different MOA available (FRAC 2014), prior to 2013 all 
registered formulations for barley powdery mildew in WA contained a triazole (Table 1; 
Figure 3). Triazole fungicides have a specific single-site MOA, targeting the product of the 
CYP51 gene (sterol 14α-demethylase) thereby disrupting the synthesis of Ergosta-5,24(241)-
diene-3β-ol, the main sterol component of cell membranes in powdery mildews (Loeffler, 
Butters et al. 1992). Resistance to this class is now well documented in both clinical and 
agricultural fungal species where it can be acquired by (i) alterations in the CYP51 gene 
which disturbs binding of the triazole at the target site (Mullins, Parker et al. 2011), (ii) 
CYP51 overexpression thereby increasing levels of  sterol 14α-demethylase (Ma, Proffer et 
al. 2006) and (iii) an increased efflux of triazoles mediated through the presence of 
membrane-bound transported proteins (Da Silva Ferreira, Luiz Capellaro et al. 2004). As yet 
mutations in Bgh CYP51 have been reported only in UK isolates of Bgh that were less 
sensitive to the triazole fungicide triadimenol (Wyand and Brown 2005). 
For almost a decade, growers in WA have been reporting a decline in the efficacy of the 
widely used triazole tebuconazole (GRDC 2012). First registered in 1995 (APVMA 2014) 
(Table 1), tebuconazole provided protective, eradicative and curative action against many 
barley diseases common in WA including rusts (Puccinia spp.) and powdery mildew 
(MacBean 2012). Few new products were registered for BPM control from this time until 
2004 when the expiry of patents saw the market flood with formulations from international 
manufacturers, supplying chemicals at a fraction of the previous price (Figure 3) (Paton 
2014). The first strobilurin (QoI) fungicide, azoxystrobin, was introduced in 2004 as a 
mixture with a triazole, cyproconazole (APVMA 2014). Additional formulations containing 
QoIs were incorporated in subsequent years but always mixed in patent formulations 
containing various triazole partners. BPM resistance to QoI fungicides has been detected in 
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European populations (Bäumler, Felsenstein et al. 2003) but as yet has not been found in 
Australia (Tucker, unpublished).   
Local reports of triazole field failures have been circulating since 2005. Despite this, new 
formulations that were devoid of triazole fungicides were not registered until seven years 
later. The 2013 cropping seasons saw the first spiroketal-amine product registered in a 
formulation containing spiroxamine (Table 1, Figure 3) (APVMA, 2014). Spiroxamine also 
targets a key enzyme in the ergosterol biosynthesis pathway, ERG24 encoding C14 sterol 
reductase (Jia et al. 2002). Although, both triazole and spiroketal-amine fungicides target the 
same essential biochemical pathway, no cross resistance between compounds of the two 
groups has been reported (FRAC, 2014). 
Did this widespread and prolonged use triazoles contribute to the build-up of resistant BPM 
isolates in WA? To answer this we began a study in 2009 to examine whether resistance to 
triazoles had evolved in the Bgh population in WA. 
  
 2.3.2 Genetics of triazole resistance 
Several studies have dissected the relationship between mutational changes in the triazole 
target gene, CYP51, with triazole efficacy failures in the field. To date, two mutational 
changes in CYP51 have been reported in BPM isolates from the UK. A tyrosine to 
phenylalanine substitution at amino acid 136 (Y136F) and a lysine to glutamine change at 
amino acid 147 (K147Q), were found in isolates that had reduced sensitivity to the triazole 
triadimenol (Wyand and Brown 2005). To determine whether mutational events were causing 
loss of efficacy in WA fields, a pilot study was initiated in 2009 whereby isolates of Bgh 
were phenotyped in response to tebuconazole and their CYP51 sequence was obtained. In 
2009 the Y136F mutation was identified in WA isolates, although no correlation could be 
drawn between the presence of the mutation and the failure of tebuconazole in the field as 
wild-type Bgh isolates were never found (Tucker, Lopez-Ruiz et al. 2015). 
CYP51 sequences were obtained from additional isolates in subsequent seasons and further 
mutations were identified. The Y136F mutation was found to be ubiquitous throughout 
Australia. WA isolates harboured additional modifications of which a change from serine to 
threonine at amino acid 509 (S509T) was the most significant (Tucker, Lopez-Ruiz et al. 
2015).Isolates harbouring the S509T mutation were consistently less sensitive to all 
formulations tested (Figure 4). The most commonly used triazole, tebuconazole, was most 
badly affected by the mutation and this presumably explains its loss of field efficacy. The 
prevalence of the S509T mutation increased from non-existent in isolates collected in 2009 to 
almost universal in WA in 2011 (Figure 5). A homology search revealed that the S509T 
mutation aligned with the S524T change in Zymoseptoria tritici, previously characterised as 
conveying reductions in triazole sensitivity (Cools and Fraaije 2013). We conclude that 
tebuconazole has selected for the Y136F/S509T mutant which is capable of proliferation even 
in the presence of field rates of tebuconazole.  
 2.3.3 Strategies for combatting triazole resistance of Bgh 
Genetic changes occur randomly in the field. They only become a problem when a resistant 
mutant form proliferates to become dominant in the population (van den Bosch, Oliver et al. 
2014). It is therefore quite feasible that the Bgh CYP51 mutations Y136F and S509T were 
present in the WA population long they were first detected in 2009 and 2010 respectively. 
 
 
75 | P a g e  
 
Microsatellite studies have determined that these mutations occurred numerous times and in 
numerous sites around the state (Tucker unpublished). Hence, we conclude that the increase 
in frequency has been caused by successive selection for Y136F/S509T mutants. 
Until recently, triazoles dominated the market for foliar fungicides in WA. Products that also 
contain a QoI were introduced in 2004 and 2008 (Table 1).  A formulation containing 
spiroxamine, registered in 2013, is the only product available that does not contain a triazole. 
In contrast in the UK 50 compounds having 15 different MOA are registered for use on 
spring barley (FRAG 2014). There are clearly many fungicides that are not currently 
accessible to WA growers. Furthermore, five of the fungicides registered in the UK are multi-
site inhibitors, which have proven to have a low risk of resistance development. There is an 
immediate need to fast track the registration of chemicals with new MOA that have already 
been thoroughly assessed for use on many barley diseases. 
The primary strategy recommended to manage resistance to any fungicide class is to mix or 
alternate with another fungicide with a different mode of action (Brent and Hollomon 2007). 
The at-risk fungicide, which usually provides great disease control, can be protected against 
resistance breakdown by the inclusion of an active with a different MOA, either in a tank mix 
or alternating spray applications. The partner compound could ideally be a multi-site 
inhibitor, presumed to have a low resistance risk, or an unrelated single-site fungicide. The 
concept behind this arises from the expectation that mutants have evolved resistance to one 
fungicide MOA would still be sensitive to a different MOA (van den Bosch, Oliver et al. 
2014) . Thus there is an absolute requirement for registrations of numerous MOA that can be 
rotationally applied in attempt to suppress resistance build-up. 
The widespread use of highly susceptible cultivars and the repeated use of a single mode of 
action fungicide was a perfect recipe for an epidemic of fungicide resistance. For a period of 
nine years there have been reports on field failure of tebuconazole in controlling BPM 
outbreaks (GRDC 2012). During successive seasons, BPM infections have been highly 
damaging and widespread resulting in reductions of yield from 2.91 t/ha to 1.76 t/ha and 
downgrading of grain to feed quality (NVT 2014). Annually an average of 1.3m ha 
(ABARES 2014) is planted in WA and receival ports indicate that 55% of barley grain taken 
was susceptible to BPM infection (CBH 2014). Given these figures we estimate that the 
epidemic of highly virulent and tebuconazole resistant Bgh has caused at least AU$100M 
anually.in losses in WA alone. This may well be the most damaging and costly fungicide 
resistance outbreak ever recorded.  
 
3.1 Conclusions and Future Prospects 
 In the case of BPM, the factors that have been shown to contribute to fungicide resistance 
had been previously well recognised (Wyand and Brown 2005). BPM resistance to triazole 
fungicides has been documented since1981 (Fletcher and Wolfe 1981; FRAC 2013). 
Tebuconazole was registered for Bgh control in WA, 14 years later. Strategies for resistance 
management such combining or alternating triazoles with a different MOA, decreasing dose 
(van den Bosch, Paveley et al. 2011) or spraying before complete crop infection, could have 
been introduced. 
Unfortunately for a number of diseases, including BPM, the rate of loss of effective 
fungicides threatens to exceed the rate of introduction (van den Bosch, Oliver et al. 2014) and 
this is very much the present situation in Australia. Maintaining an array of effective 
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fungicides with many different MOA is critical. Many fungicides with different MOA are 
registered overseas and these could be made available to Australian growers. This would 
provide more options for resistance management. As well as new fungicides, an ongoing 
program monitoring in shifts in resistance in the pathogen population would be needed to 
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Table 1. The year of first registration of the foliar active compounds permitted for barley 








Azoxystrobin + Cyproconazole 2004 
Propiconazole + Cyproconazole 2004 
Epoxiconazole 2005 
Epoxiconazole + Pyraclostrobin 2008 
Tebuconazole + Flutriafol 2009 
Tebuconazole + Prothioconazole 2009 
Azoxystrobin + Tebuconazole 2012 
Spiroxamine 2013 
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Table 2. Popular cultivars grown in the west of Australia with resistance genes and powdery 






in WA Bghb 
Powdery mildew 
susceptibilityc 
Baudin Ml-a8 Yes VS 
Vlamingh Ml-a8 Yes S 
Gairdner Ml-g Yes S 
Hamelin Ml-g Yes S 
Stirling None - S 
Bass Ml-a8, Yes, MS 
Hindmarsh Ml-a8, Ml-La Yes, Yes MRMS 
Buloke Ml-a7,Ml-La Yes, Yes MR 
 
a As postulated by Dreiseitl and Platz (2012) 
b Results published by Tucker et al. (2013) 
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Figure captions 
Figure 1: Map of the Western Australian Wheat Belt. Grey shading indicates areas that barley 
is grown with mildew densities indicated in black.  
Figure 2. Percent of Western Australian growing area seeded with barley cultivars from 2005 
to 2013.  Colour blocking indicates resistance profile to barley powdery mildew and are as 
follows; Very susceptible – black, susceptible – dark grey, moderately resistant – light grey 
and resistant – white. Letters indicate cultivars (a) Schooner, (b)Barque, (c) Dash, (d) Bass, 
(e) Yagan, (f) Scope and (g) Hindmarsh. Data obtained from CBH grower estimates 2005-
2013.  
Figure 3: Number of registered formulations for use on barley powdery mildew from 1995 to 
2014 (APVMA, 2014). Single triazole formulations are shaded grey. Formulations mixing 
two triazoles are indicated with thick black lines and formulations containing fungicides with 
a different MOA to triazoles are unfilled. Letters indicate formulations containing (a) 
spiroxamine, (b) axoxystrobin and tebuconazole, (c) flutriafol and tebuconazole (d) 
epoxiconazole and pyraclostrobin, (e) epoxiconazole (f) cyproconazole and propiconazole (g) 
azoxystrobin and cyproconazole and (h) triadimefon. 
Figure 4: Average EC50 (μg mL
-1) of a collection of Australian Bgh isolates that are either 
S509 (black area) or T509 (grey area) in CYP51. Each axis represents a triazole EC50.Teb – 
tebuconazole, Epoxi – epoxiconazole, Propi – propiconazole, Triad – triadimefon, Prothio – 
prothioconazole, Flut – flutriafol or Cyp – cyproconazole. Outermost ring corresponds to 25 
μg mL-1 with each preceding ring representing a 5 μg mL-1 reduction as indicated. 
Figure 5: The proportion of Bgh isolates with mutant T509 CYP51 alleles collected in 
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Summary 
 Powdery mildew caused by Blumeria graminis f. sp. hordei (Bgh), is a constant threat to 
barley production but is generally well controlled through combinations of host genetics and 
fungicides. Reductions in the efficacy of triazole fungicides in controlling Bgh have recently 
been reported in the west of Australia (WA).  Our study examined the sensitivity of Bgh 
isolates to triazoles and determined the molecular basis for loss of efficacy.  
 The triazole target gene, CYP51, was sequenced from Bgh isolates and five amino acid 
substitutions were found or which four were novel.  
 A clear association was established between combinations of mutations and altered levels of 
resistance to triazoles with both negative and positive cross-resistance observed. In vitro 
results were confirmed by in silico protein docking studies. 
 The in silico appraisal of binding efficiencies between specific triazoles and CYP51 variants 
promises to facilitate the design of resistance management strategies that counterselect the 
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Introduction 
Blumeria graminis f. sp. hordei (Bgh) is an ascomyceteous fungus causing barley (Hordeum 
vulgare L.) powdery mildew. In conducive seasons this biotrophic pathogen has the potential 
to  reduce yields by as much as 20% (Murray and Brennan 2010). In most places Bgh is well 
controlled by host genetics (both the durable recessive mlo gene (Buschges, Hollricher et al. 1997) 
and combinations of minor genes ) and fungicides (from the triazole, quinone and succinate 
dehydrogenase inhibiting (SDHI) classes as well as a number of specific mildewcides (FRAG 
2014)). Since 1995 the majority of the west Australian (WA) barley area has been planted to 
susceptible cultivars and there has been a steep increase in triazole fungicide use since 1995. 
In 2009, 85 % of barley crops were treated with one or more sprays almost exclusively of 
triazole fungicides (Murray and Brennan 2010; ABARES 2014).  
Triazole fungicides have been in the forefront of control of fungal pathogens of humans, 
animals and plants for nearly 40 years (Brent and Hollomon 2007). These fungicides interrupt 
the biosynthesis of ergosterol, an essential component of fungal cell membranes, by 
inhibiting the cytochrome P450 14α-sterol demethylase (CYP51) (Dupont, Lemetais et al. 
2012). Resistance is now common in human pathogens, including Candida spp. (Hull, Parker 
et al. 2012; Xiang, Liu et al. 2013) and Aspergillus fumigatus (Lelièvre, Groh et al. 2013), 
and is a serious problem in agricultural systems (Cools and Fraaije 2013). Fungicide 
resistance has been associated with the alteration and overexpression of the CYP51 protein 
and enhanced triazole efflux (Sanglard, Kuchler et al. 1995; Nakaune, Adachi et al. 1998; 
Gisi, Chin et al. 2000; Ma and Michailides 2005; Cools and Fraaije 2008; Hulvey, Popko Jr 
et al. 2012; Cools and Fraaije 2013).  
 
Two earlier studies have noted changes in Bgh CYP51 coding sequence (Y136F and K147Q) 
present in isolates less responsive to triazoles (Délye, Bousset et al. 1998; Wyand and Brown 
2005). As K147Q was never found alone and Y136F was found in isolates with both low and 
high levels of triadimenol resistance, the exact sensitivity shift afforded by each was unclear. 
In these cases field resistance arose despite a complex pattern of simultaneous use of many 
fungicide modes of action (MOA) and the widespread use of other pathogen counter 
measures. In contrast, in WA the vast majority of the area was sown to susceptible cultivars 
and only a single class of fungicide was used (Tucker, Lopez-Ruiz et al. 2014). This has 
allowed us to chart the development of a major epidemic. 
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Many growers from southern WA reported a reduction in the effectiveness of triazoles in 
controlling barley powdery mildew outbreaks (GRDC 2012). Tebuconazole-containing 
formulations have been popular due to their  low cost and spectrum of activity (Tucker, 
Lopez-Ruiz et al. 2014). Since 2005, accounts of mildew infection on barley sprayed with 
tebuconazole formulations have extended over much of the southern agricultural region with 
the frequency of reports increasing in recent years (Lord and Kehoe 2014).  
In this study we have determined the sensitivity of Australian Bgh isolates to triazole 
fungicides registered in WA. Sequencing of the CYP51 coding region in a subset of isolates 
revealed four unique genotypes. We have characterised the impact of these mutations on 
triazole sensitivity by in vitro assays and by heterologous expression in Saccharomyces 
cerevisiae. The results link variations in triazole sensitivities to changes in the CYP51 coding 
region that are predicted to alter the heme binding pocket. Protein structural modelling and 
triazole docking was able to rationalise the observation of both positive and negative cross 
resistance. The results clearly demonstrate how misuse of pesticides leads directly to 
resistance in Bgh and validate how molecular methods accelerate the discovery of solutions. 
Materials and Methods 
Blumeria graminis f. sp. hordei  
Isolates 
One hundred and nineteen Bgh isolates were collected from Australia from 2009 to 2013 
(Figure 1, Supporting Information Table S1). Isolates from Wagga Wagga, Tamworth (New 
South Wales) and Launceston (Tasmania) were supplied by the Department of Environment 
and Primary Industries, Victoria. Isolate purification, sub-culturing and assessments of 
growth were performed according to Tucker (2013).  
Fungicide sensitivity assays 
Fungicide sensitivities were determined in vitro by assessing growth of 18 Bgh isolates on 
susceptible (cv. Baudin) barley leaves inserted into fungicide-amended media with a no 
fungicide control. Commercial formulations of triazoles currently registered for Bgh control – 
Laguna (720g L-1 tebuconazole, Sipcam), Flutriafol (250g L-1 flutriafol, Imtrade Australia), 
Opus (125g L-1 epoxiconazole, Nufarm), Alto (100g L-1 cyproconazole, Nufarm), Tilt (418g 
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L-1  propiconazole, Syngenta), Proline (410g L-1 prothioconazole, Bayer Crop Science), Triad 
125 (125g L-1 triadimefon, Farmoz) and Jockey Stayer (167g L-1 fluquinconazole, Bayer Crop 
Science) were incorporated into agar amended with 50mg L-1 of benzimidazole (Chan and 
Boyd 1992). Middle sections of 10 day old seedlings were excised with each tip inserted 
abaxial side up into fungicide amended agar. Each isolate was used to inoculate three 
replicates on subsequent weeks with conidia dislodged 24h before use to promote fresh 
growth. Conidal suspensions were collected on glossy black paper and blown into a 1.5m 
infection tower to ensure even inoculation. Following seven days growth at 20±2°C subject to 
a 12:12 h light :dark photoperiod  the growth of each isolate and fungicide concentration was 
assessed using a 0-4 infection type (IT) scale adapted from Czembor (2000). Each pustule 
formation (or lack thereof) was assigned an IT and the average for each isolate and fungicide 
concentration pair was determined. Both the average IT and concentration was log 
transformed, % inhibition calculated and plotted against  the transformed concentration to 
determine the regression equation and correlation coefficient.  The mean 50% effective 
concentration (EC50) and strength of the linear relationship between the two variables was 
determined. Resistance factors (RF) were calculated as the fold change in the average EC50 of 
T509 CYP51 isolates compared to S509 isolates (Supporting Information Table S2). Data 
analysis was conducted in JMP, v10 (SAS Institute Inc. Cary, NC). 
CYP51 sequencing  
DNA isolations were performed using a BioSprint 15 DNA Plant Kit (Qiagen) following the 
manufacturer’s instructions. The wild type Bgh DH14 isolate (GenBank accession no. 
AJ313157) was used to design primers (Supporting Information Table S3) covering the 
length of the Bgh CYP51 (Bgh51) gene (Supporting Information Fig. S1). Both the coding 
sequence and promoter region of 76 isolates were sequenced using Sanger sequencing and 
aligned in Geneious v 5.5 (Biomatters). A homology search was conducted between the 
Australian Bgh CYP51 genotypes with other published CYP51 variants. All sequences have 
been submitted to GenBank (Accession no. KM016902, KM016903, KM016904 and 
KM016905). By employing a high-throughput method of S509 and T509 allele detection 
((digesting the amplicon of Bgh51_3F and Bgh51_3R with Hpy8I) (Supporting Information 
Table S3)), the CYP51 509 genotype of all 119 isolates was obtained. 
Yeast Phenotyping 
Strains and complementation of transformants  
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Synthesis of the wild type (wt) DH14 (Accession no. AJ313157) CYP51 gene (Bgh51wt) was 
carried out by GENEWIZ Inc. (South Plainfield, NJ). Terminal restriction enzyme 
recognition sites for Kpn1 and EcoR1 were added at the 5’ and 3’ ends respectively. The 
pYES-Bgh51wt expression plasmid was constructed by cloning the synthesized Bgh51wt into 
the pYES3/CT vector (Invitrogen, Carlsbad, CA). The full length Bgh51wt gene in pYES-
Bgh51wt was sequenced to ensure the validity. Transformations into S. cerevisiae strain 
YUG37:erg11 (MATa ura3-52 trp1-63 LEU2::tTa tetO-CYC1::ERG11) with native Cyp51 
gene under the control of a tetO-CYC1promoter, repressed in the presence of doxycycline 
(Parker, Merkamm et al. 2008). All complementation assays were preformed according to 
Cools et al (2010) with photographs taken following 72h of growth at 20°C (Supporting 
Information Fig. S2). Mutations found in Bgh51 of Australian isolates were introduced into 
pYES-Bgh51wt through a QuickChange II site-directed mutagenesis kit (Stratagene, La Jolla, 
CA). 
Comparative growth rate assay of transformants  
The growth rate of transformants was assessed using Gen 5 data analysis software (BioTek 
Instruments, Inc. Winooski, VT) where duplicate cultures of replicate transformants were 
grown in SD GAL + RAF medium (SD medium) overnight at 30°C. One hundred microliters 
of each overnight culture, at 105 cells ml-1, was used to inoculate 3 wells containing 200μl SD 
medium ±3μg ml-1 doxycycline. Cultures were incubated without light at 30°C, and the 
optical density at 600nm (OD600) was measured every 15min for 12 days in a Synergy
TM HT 
Multi-Mode Microplate Reader (BioTek Instruments, Inc Winonski, VT). The mean 
maximum growth rate for each strain ± doxycycline was determined on the basis of the 
greatest increase in OD over a 2h period (Supporting Information Table S4). 
Fungicide sensitivity assays 
Sensitivity assays were carried out as described by Cools et al. (2010) using pure samples of 
tebuconazole, cyproconazole, propiconazole, epoxiconazole, fluquinconazole, triadimefon, 
flutriafol and desthio-conazole with a fungicide free control. It should be noted that as 
prothioconazole must be metabolised in plant tissue for it to be active (Parker, Warrilow et al. 
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Structural modelling of Bgh51wt and mutant forms was undertaken using an automated 
homology modelling platform as previously described for Z. tritici CYP51 (Mullins, Parker et 
al. 2011). Ligand docking of epoxiconazole and fluquinconazole were also carried out as 
previously described (Mullins, Parker et al. 2011). The volume of the heme cavity of the wild 
type and variant protein models was determined using Pocket-Finder (Leeds, UK) which is a 




To determine whether mutational events caused the variance in the response of WA Bgh 
isolates to triazoles, primers were designed covering both the coding and promoter region of 
the single CYP51 gene (Becher and Wirsel 2012) in Bgh (Supporting Information Table S3, 
Supporting Information Fig. S1). The Bgh51wt DH14 sequence was used as a reference 
(Spanu, Abbott et al. 2010). No indels were found in the promoter region of any isolate (data 
not shown). The Cyp51 coding region was sequenced from 76 Australian isolates collected 
over from 2009 to 2013, including three from the east of Australia. Several synonymous and 
non-synonymous changes were identified (Supporting Information Fig. S3). All three isolates 
from the east of Australia carried two synonymous changes at nucleotides 81 and 1475, 
which were absent in WA isolates. All the Australian isolates carried the tyrosine to 
phenylalanine mutation at amino acid position 136 (Y136F) previously seen by Delye et al. 
(Délye, Bousset et al. 1998) and Wyand and Brown (Wyand and Brown 2005). Further non-
synonymous mutations were found; K171E, M301I, R327G and S509T in various 
combinations (Figure 2). Considering only the non-synonymous changes, four novel Bgh51 
genotypes were distinguished. Isolates collected in WA were either F136/T509 (genotype 2) 
or F136/I301/G327/T509 (genotype 4) while isolates from other Australian states were either 
F136/E171 (genotype 3) or F136 (genotype 1). Mutations I301 and G327 were consistently 
found in the same isolates (Figure 2). 
There was both spatial and temporal variation in the frequency of genotypes (Figure 1, 
Supporting Information Table S1). All isolates collected in 2009 were wild type at CYP51 
position 509. The proportion of S509 isolates collected declined dramatically over subsequent 
seasons to as low as 0.07 in 2011 (data not shown). Ninety nine of the 116 WA isolates 
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analysed contained the T509 mutation. These mutants were found in all major WA barley 
growing areas (Figure 1). 
Triazole sensitivities of Bgh isolates 
The sensitivities of Bgh isolates were determined using detached barley leaves inserted into 
triazole-amended agar. The results varied between genotype and fungicide (Figure 3, 
Supporting Information Fig. S4). There were no significant differences between isolates of 
genotype 1and 3 or between isolates that were genotype 2 or 4. For this reason we focussed 
on whether isolates contained the S509T mutation. Isolates of genotype 1 and 3 were 
consistently more sensitive to all foliar fungicides tested. The RFs were highest for genotypes 
2 and 4 in the presence of tebuconazole and flutriafol (Figure 3). For fluquinconazole (used in 
WA solely as a seed formulation), the T509 isolates were marginally more sensitive 
suggesting negative cross resistance to this compound. Unfortunately, due to quarantine 
restrictions we were not able to phenotype the wild type DH14 isolate. 
Heterologous expression in yeast 
The Bgh51wt gene (i.e. as found in DH14) was synthesized and cloned into S. cerevisiae 
YUG37:erg11 with a doxycycline repressible promoter. The S. cerevisiae Bgh51wt 
transformant was able to grow in the presence of doxycycline (Supporting Information Fig. 
S2). There was no significant difference in the growth rates of all variants in the absence of 
doxycycline. However two S. cerevisiae Bgh51 variants had significantly lower rates of 
growth in the presence of doxycycline (pYES-Bgh51_Y136F/S509T/R327G and pYES-
Bgh51_Y136F/M301I/R327G/S509T)  and were removed from all further in vitro analysis. 
The triazole sensitivities of S. cerevisiae strains expressing Bgh51 variants which restored 
growth on doxycycline-amended medium were determined (Supporting Information Table 
S5) and resistance factors were calculated (Table 1). Modest RFs were associated with the  
solo K171E and M301I mutations. RFs for the  S509T mutation varied from 0.5 for 
fluquinconazole to 12.4 for propiconazole.  Resistance for the solo Y136F mutation, which 
has been found in nature in Bgh, were also modest except for fluquinconazole having a RF of 
9.7, confirming the marginal cross resistance detected in the detached leaf assays. The 
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For many mutations fluquinconazole displayed outlier results. The RF for Y136F was 
strongly positive (9.7) whereas the RF for all other mutation combinations was 0.1 to 0.5  
indicating greater sensitivity than the wild type construct  
Structural modelling 
The mutant protein variants of all Bgh51 genotypes were structurally modelled (Supporting 
Information Fig S5). The effect of each mutational change on the volume of the heme cavity 
and distance from key amino acids around the cavity entrance was determined (Table 2). 
Modest volume increases were observed with the solo mutations; a 17.7% increase with 
K171E and 39.6% increase in volume with Y136F. Mutation S509T was an exception, with 
an increase in volume of 73.2% compared to that of the wild type model. The combination of 
F136/T509 gave a more substantial increase of 83.9%.  
 
Table 2 also shows the estimated distances between Y222 and S506, which measures along 
the region of the access channel adjacent to the triazole binding site. Unlike the volume of the 
heme cavity, single mutational changes such as K171E and M301I decreased the diameter of 
the access channel by 7.8% and 6.6% respectively, compared to the wild type. The major 
conformation change is brought about through the acquisition of the Y136F mutation, which 
restricts the channel opening of the wild type model by 28.5%. The combination of F136 and 
T509 in a single model only slightly decreases the channel over the Y136 model to 28.7% of 
that of Bgh51wt. 
 
The predicted binding pocket size and the diameter of the access channel were combined to 
elucidate the overall change of each genotype compared to the wild type. It appears that each 
of the two mechanisms can operate singly or in combination. This gives a possible 
explanation as to why the Y136F mutation, which brings about only a modest increase in 
cavity volume, results in notable resistance to tebuconazole. This is possibly due to the 
constriction of the access channel (from Y222 to S506) from 17.4Å to 6.5Å. The 
conformation of a loop of beta turn running from S505 to F508 is markedly different to that 
of the wild type, with the result that it projects into the cavity. A similar constriction is 
observed for the F136/T509 mutant (Supporting Information Fig. S5b). However, in this case 
it is also accompanied by a substantial increase in cavity volume (Table 2), consistent with 
the exceptional resistance factors observed. It is interesting to note that this loop is adjacent to 
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S509. This supports the idea that the structural changes brought about by the Y136F mutation 
on its own may exert selective pressure on the 509 position, leading to the F136/T509 mutant. 
 
Fluquinconazole docking studies were carried out to elucidate the mechanistic reasons for the 
cross resistance patterns (Figure 4b). In the wild type structure, the binding site of 
fluquinconazole is bordered by amino acids Y122 and Y222. It appears that the position of 
Y122 is particularly important in establishing the correct orientation of fluquinconazole so as 
to be coordinated by the heme. This arrangement is disrupted in the Y136F mutant, where 
Y122 and S506 prevent fluquinconazole accommodation (Figure 4b). With the Y136F/S509T 
mutant, Y122 is positioned similarly to the wild type, allowing accommodation of 
fluquinconazole as in the wild type. Here S506 borders the binding site and is predicted to 
interact with the fluquinconazole ligand (Figure 4c). Thus it appears the relative 
inconsistency of the Y136F mutant and enhanced selection of the Y136F/S509T double 
mutant can be explained by the 3D docking results. 
Discussion 
Studies best exemplified by the wheat pathogen Z. tritici, have discussed the relationship 
between mutational changes in CYP51 with failures of triazole fungicides in the field. 
Triazoles have been used since the first registration of triadimefon in 1973 in the UK (Russell 
2005). Twenty years after its introduction, Z. tritici isolates were found with CYP51 changes 
conferring reductions in sensitivity (Cools and Fraaije 2013). Subsequently, numerous azoles 
have been introduced and 34 additional CYP51 mutations have been identified (Cools and 
Fraaije 2013). This long history and the recent identification of mutations has made it 
difficult to discern cause and effect. The situation in WA is simple: triazole use has been 
widespread since 2004 and the first reports of resistance date from 2005.  
Analysis of Cyp51of Australian Bgh isolates collected from 2009 to 2013 revealed four 
genotypes. The in vitro sensitivities of isolates from different genotypes varied between the 
triazoles tested. Bgh isolates with genotypes harbouring the S509T mutation were less 
sensitive to all the foliar fungicides used on barley in WA. In the case of fluquinconazole 
(which is only currently registered in WA as a seed treatment) isolates harbouring the T509 
CYP51 allele were more sensitive than their S509 counterparts. The Y136F mutation was 
found in all isolates examined including those from the east of Australia. As yet there have 
been no reports of field failure in this region.  
 
 
99 | P a g e  
 
This mutation was previously correlated with strong resistance to triadimenol (Wyand and 
Brown 2005). We cannot test the wild type CYP51 Bgh isolate in Australia due to quarantine 
restrictions. Y136F expression in yeast showed modest but significant decreases in sensitivity 
to most triazoles (Table 1). We therefore assume that there would be small differences in 
field efficacy that are unlikely to be noticeable. This suggests that even the limited fungicide 
use in the east of Australia has been sufficient to select for this mutation (Murray and 
Brennan 2010). If the new S509T mutation integrates into eastern populations of Bgh or is 
selected in situ, tebuconazole breakdown is inevitable and may no longer be an option for 
disease control in Australia. 
Figure 3 compares the in vitro EC50 with the field rates for triazole foliar fungicides. 
Registered maximal application rates range from 125g ha -1 for tebuconazole, flutriafol, 
propiconazole and triadimefon to 65g ha -1 for epoxionzaole, cyproconazole and 
prothioconazole. It is clear that the high EC50 for tebuconazole means that strains harbouring 
the Y136F/S509T genotype are essentially resistant to field rates of this fungicide as the dose 
rate safety margin is less than for other registered compounds  In yeast, assays are more 
precise and there was a consistent pattern whereby large RFs were associated with strains 
carrying both the Y136F and S509T mutations for all triazoles except fluquinconazole.  
A search was conducted on the CYP51 mutations in other fungal species reported as 
conferring a reduction in triazole sensitivity. The Bgh51 amino acid sequence of Australian 
genotypes was aligned with Z. tritici CYP51 (Figure 2). Mutational changes at the amino 
acids 136, 301, 327 and 509 fall in regions conserved between Bgh and Z. tritici (Becher and 
Wirsel 2012). Amino acids 136 and 509 in Bgh51 correspond to 137 and 524 in Z. tritici 
which have previously been correlated with reductions in triazole sensitivity (Cools, Mullins 
et al. 2011). In our studies the combination of Y136F/S509T encoded a CYP51 with a marked 
decrease in sensitivity to tebuconazole that can account for the field failure (Figure 3). The 
relationship between the combination of these two mutations and reduced efficacy was 
confirmed by the yeast expression data. Increases in heme cavity volume and restriction of 
the access channel in Y136F/S509T protein models correlate well with the significant RF 
obtained (Figure 5). 
Both positive and negative selection was observed in the in vitro Bgh and yeast expression 
studies. The widespread use of tebuconazole on very susceptible cultivars appears to account 
for the selection of the more damaging Y136F/S509T combination since 2005 (APVMA 
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2014). The prior selection of Y136F, although insignificant in field terms, paved the way for 
the selection of further mutations in isolates, capable of surviving field application rates of 
the most widely used fungicides. 
Structural modelling suggests that there are two main mechanisms that underpin the 
emergence of triazole resistance associated with mutational changes in Bgh51. The first 
mechanism is similar to that observed in Z. tritici CYP51 (Mullins, Parker et al. 2011), where 
the gross volume of the heme cavity increases with successive mutations (Table 2). There 
appears to be a correlation between the increase in cavity volume and the RFs reported in 
table 1. It is likely that any increase in heme cavity volume would perturb the orientation of 
the triazole ligand and hence its binding to the heme. This therefore isolates the smaller to 
medium size triazole ligands such as tebuconazole and epoxiconazole. 
 
The second mechanism at play provides a means of linking structural changes with 
phenotypic changes in a measurable way. Changes in distances between specific pairs of 
residues that border the cavity result in changes to the diameter of the access channel. The 
limiting of the binding surface between Y222 and S312 appears to correlate well with 
resistance to tebuconazole. The narrowing of the access channel between Y222 and S506 
correlates particularly well, especially when tempered by consideration of the effects of each 
variant on the cavity volume. This is demonstrated by the result obtained when the product of 
the percent change in the heme cavity volume is multiplied by the percent change in the 
distance between Y222 and S506 (Figure 5). All the variants that contain F136 demonstrate a 
substantially reduced distance between Y222 and S506 (Table 2). When one of the 
mechanisms is employed, moderate resistance factors are observed (F136 (access channel 
narrowing); T509 (substantial increase in cavity volume)). Although, when both mechanisms 
act together there is a strong correlation between the structural changes and the very high 
resistance factors of the F136/T509 mutants in the presence of tebuconazole. The in silico 
creation of Bgh51wt and mutant CYP51 protein variants opens the possibility of future 
docking studies employing novel or unregistered triazole fungicides. This will allow the 
prediction the effectiveness of any new product prior to in planta testing. Furthermore, we 
can now recommend bespoke spray regimes depending on which Bgh51 genotype is present 
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One of the major resistance strategies used for fungicides is to mix active compounds with 
different MOA (van den Bosch, Oliver et al. 2014). The concept here is that isolates with 
mutations conferring resistance to one fungicide will most likely still be sensitive to the 
second mixing partner (van den Bosch, Oliver et al. 2014).Negative cross-resistance within a 
single MOA group has been shown in vitro with mutant Z. tritici isolates which are highly 
resistant to tebuconazole but fully susceptible to prochloraz (Fraaije, Cools et al. 2007; 
Leroux, Albertini et al. 2007). The negative cross-resistance shown in both the Bgh in vitro 
(Figure 3) and yeast expression studies (Table 1) was confirmed using in silico protein 
docking studies. Here the single Y136F mutation substantially impaired the binding of 
fluquinconazole (Figure 4). In contrast, the binding of fluquinconazole at the docking site of 
the Y136F/S509T protein model was much akin to that of the wild-type.  Fluquinconazole 
would be expected to efficiently select for Y136F but counter select the more T509 
genotypes. We therefore suggest that fluquinconazole be trialled as a means to control this 
epidemic. Nonetheless there is an immediate need for the registration of formulations with 
novel MOA and breeding of cultivars with durable resistance.  Even if fluquinconazole 
effectively counter selects the S509T mutation, its efficacy would more than likely be short 
lived given Bgh’s propensity for adaptation (data not shown). However these studies do 
provide a means of testing the likely efficacy of any currently available triazole and will 
permit the in silico exploration of novel triazoles. The affinity for the wild type and any 
mutant CYP51 variants can now be compared thereby fast tracking the design, development 
and registration of new compounds not affected by current mutations.  
The widespread use of highly susceptible varieties and the repeated use of a single MOA 
fungicide was a perfect recipe for an epidemic of fungicide resistance. A review covering the 
decade from 1999 to 2009 estimated that Bgh in WA caused losses of AU$30M p.a. (Murray 
and Brennan 2010). The area sown to barley was approximately 1.3 m ha (ABARES 2014) 
and 55% of the delivered grain was from cultivars rated as susceptible to powdery mildew 
infection (CBH 2014). The epidemic of highly virulent (Tucker, Jayasena et al. 2013) and 
tebuconazole resistant Bgh in WA is estimated to have reduced average yield from 2.91 t/ha 
to 1.76 t/ha (NVT 2014) and reduce the quality of grain from malt to feed grade. Based on 
these figures, and an average grain price of $268/t for malt barley and $231/t for feed 
(DailyGrain 2014), the epidemic of WA tebuconazole resistant Bgh caused at least an average 
of AU$100M p.a. from 2007 to 2010.  
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Figure Legends 
Figure 1: Sample sites of Bgh isolates collected from Australia. Black triangles indicate 
mutant T509 CYP51 isolates (n = 119). Grey triangles indicate isolates with CYP51 genotype 
S509 (n = 24). Numbers within triangles indicate isolates collected at each site.  
Figure 2: Sequence alignment of fragments of the CYP51 protein family. Changes found in 
Australian Bgh isolates from wild-type DH14 (GenBank: CAC85622, Wyand and Brown, 
2005) are indicated in black. Numbers represent amino acid positions with assigned 
genotypes (Gen) given. Bgh isolates Pshk1 and Pshk2 from west Australia , Frnk1 from New 
South Wales and Strl1 from Tasmania are aligned with Zymoseptoria tritici (Z. tr) isolate 
ST1 (GenBank: AAU43734, Cools and Parker et al. 2010). Boxes indicate conserved regions. 
Figure 3: Box plots of the EC50 (μg mL
-1) of a collection of Australian Bgh isolates that are 
wild-type (filled) and mutant (empty) at amino acid position 509 of CYP51. Numbers indicate 
the resistance factor (RF) of T509 over S509 isolates. Field application rates (g ha-1) are 
given as black bars.  
Figure 4: Docking of fluquinconazole in Blumeria graminis f. sp. CYP51. 
A) Wild type CYP51, showing bound fluquinconazole (in light green, centre) and steric 
interaction with Y122 (surface shown as mesh). B) The Y136F mutant, showing 
encroachment of Y122 and S506 (surface shown as mesh) upon the docking site of 
fluquinconazole, indicating that the compound cannot be bound at that location.  C) The 
Y136F-S509T mutant, showing orientation of Y122 similar to wild type and predicted 
interaction with S506 (shown in yellow).  
Figure 5: Correlation between tebuconazole resistance factor (RF) of pYES-
Bgh51_Y136F/S509T and the product of the change in the volume of the heme cavity 
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Supporting Information  
Supporting Information Table S1: Details of collection and CYP51 genotype of the seventy-
three Bgh isolates sequenced using Sanger technology in this study. 
Supporting Information Table S2: Average in vitro EC50 and resistance factors of T509 and 
S509 Bgh51 isolates when exposed to currently registered triazoles in WA. 
Supporting Information Table S3: Primers used for sequencing and site-directed mutagenesis. 
Supporting Information Fig. S1: Binding position of primers used to sequence the length of 
Bgh51 including the 5’ promoter region. 
 
Supporting Information Fig. S2: Complementation of S. cerevisiae strain YUG37:erg11 with 
wild type (Bgh51wt) and mutated variants.  
Supporting Information Table S4: Growth rate analysis of S. cerevisiae YUG37:erg11 
transformants. 
 
Supporting Information Fig. S3: Nucleotide alignment of the CYP51 gene of five isolates of 
Bgh. 
Supporting Information Fig. S4: Average in vitro EC50 (μg mL
-1) of Australian Bgh isolates 
from four distinct genotypes 1 – F136, 2 – F136/T509, 3 – F136/E171 and 4 – 
F136/I301/G327/T509. 
 
Supporting Information Table S5: EC50 and resistance factors of the pYES-Bgh51 yeast 
mutants when exposed to currently registered triazoles in Western Australia. 
 
Supporting Information Fig. S5: Structural modelling of Bgh CYP51.   
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Table 1: Resistance factors of S. cerevisiae YUG37:erg11 transformants. 
Constructa 
Resistance Factors  
Teb Epoxi Propi Desthio Cyp Flut Triad Fluquin 
pYES-Bgh51_Y136F 1.1 3.7 1.6 3.3 1.0 1.4 1.5 9.7 
pYES-Bgh51_K171E 0.9 1.4 0.6 2.1 0.9 1.0 0.9 0.2 
pYES-Bgh51_M301I 0.9 1.8 2.1 0.2 0.7 0.5 0.5 0.1 
pYES-Bgh51_S509T 3.7 7.3 12.4 1.2 2.1 2.7 3.6 0.5 
pYES-Bgh51_Y136F/K171E 1.3 2.4 1.9 0.9 0.9 1.3 3.3 0.2 
pYES-Bgh51_Y136F/S509T 33.2 18.5 340.6 0.8 3.2 10.5 23.8 0.2 
pYES-
Bgh51_Y136F/S509T/M301I 2.3 4.9 2.8 0.1 0.8 1.9 5.7 <0.1 
aNumbers refer to amino acid positions in Bgh. Resistance factors (RF) were calculated from 
the mean EC50 values of eight independent replicates. RF <1 indicates greater sensitivity than 
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Table 2: Measurements of heme cavity volume and key inter-residue distances in wild-type 













Wild-type 1809 - 12.862   
F136 2526 +39.6% 9.202 -28.5% 0.113 
E171 2130 +17.7% 11.861 -7.8% 0.014 
I301 2573 +42.2% 12.015 -6.6% 0.028 
G327 2607 +44.1% 12.074 -6.1% 0.027 
T509 3134 +73.2% 10.233 -20.4% 0.149 
F136/E171 2334 +29.0% 10.870 -15.5% 0.045 
F136/T509 3327 +83.9% 9.294 -28.7% 0.241 
F136/I301/ 
G327/T509 
2181 +20.6% 9.960 -22.6% 0.047 
 
aΔHCV – change in heme cavity volume. 
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Fig. 1: Sample sites of Bgh isolates collected from Australia. Black triangles indicate mutant 
T509 CYP51 isolates (n = 119). Grey triangles indicate isolates with CYP51 genotype S509 
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Fig. 2: Sequence alignment of fragments of the CYP51 protein family. Changes found in 
Australian Bgh isolates from wild-type DH14 (GenBank: CAC85622, Wyand and Brown, 
2005) are indicated in black. Numbers represent amino acid positions with assigned 
genotypes (Gen) given. Bgh isolates Pshk1 and Pshk2 from west Australia , Frnk1 from New 
South Wales and Strl1 from Tasmania are aligned with Zymoseptoria tritici (Z. tr) isolate 
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Fig. 3: Box plots of the EC50 (μg mL
-1) of a collection of Australian Bgh isolates that are 
wild-type (filled) and mutant (empty) at amino acid position 509 of CYP51. Numbers indicate 
the resistance factor (RF) of T509 over S509 isolates. Maximum field  application rates (g ha-
1) of currently registered triazole fungicides are given as black bars. 
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Fig. 4: Docking of fluquinconazole in Blumeria graminis f. sp. CYP51. 
A) Wild type CYP51, showing bound fluquinconazole (in light green, centre) and steric 
interaction with Y122 (surface shown as mesh). B) The Y136F mutant, showing 
encroachment of Y122 and S506 (surface shown as mesh) upon the docking site of 
fluquinconazole, indicating that the compound cannot be bound at that location.  C) The 
Y136F-S509T mutant, showing orientation of Y122 similar to wild type and predicted 























Fig. 5: Correlation between tebuconazole resistance factor (RF) of pYES-Bgh51_Y136F/S509T and 
the product of the change in the volume of the heme cavity (ΔHCV) with the change in distance 
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Summary 
 Powdery mildew caused by Blumeria graminis f. sp. hordei (Bgh), is a constant threat to 
barley production but is generally well controlled through combinations of host genetics and 
fungicides. Reductions in the efficacy of triazole fungicides in controlling Bgh have recently 
been reported in the west of Australia (WA).  Our study examined the sensitivity of Bgh 
isolates to triazoles and determined the molecular basis for loss of efficacy.  
 The triazole target gene, CYP51, was sequenced from Bgh isolates and five amino acid 
substitutions were found of which four were novel.  
 A clear association was established between combinations of mutations and altered levels of 
resistance to triazoles with both negative and positive cross-resistance observed. In vitro 
results were confirmed by in silico protein docking studies. 
 The in silico appraisal of binding efficiencies between specific triazoles and CYP51 variants 
promises to facilitate the design of resistance management strategies that counterselect the 
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Introduction 
Blumeria graminis f. sp. hordei (Bgh) is an ascomyceteous fungus causing barley (Hordeum 
vulgare L.) powdery mildew. In conducive seasons this biotrophic pathogen has the potential 
to  reduce yields by as much as 20% (Murray and Brennan 2010). In most places Bgh is well 
controlled by host genetics (both the durable recessive mlo gene (Buschges, Hollricher et al. 1997) 
and combinations of minor genes ) and fungicides (from the triazole and succinate 
dehydrogenase inhibiting (SDHI) classes as well as a number of specific mildewcides (FRAG 
2014)). Since 1995 the majority of the West Australian (WA) barley area has been planted to 
susceptible cultivars and there has been a steep increase in triazole fungicide use since 1995. 
In 2009, 85% of barley crops were treated with one or more sprays almost exclusively of 
triazole fungicides (Murray and Brennan 2010; ABARES 2014).  
Triazole fungicides have been in the forefront of control of fungal pathogens of humans, 
animals and plants for nearly 40 years (Brent and Hollomon 2007). These fungicides interrupt 
the biosynthesis of ergosterol, an essential component of fungal cell membranes, by 
inhibiting the cytochrome P450 14α-sterol demethylase (CYP51) (Dupont, Lemetais et al. 
2012). Resistance is now common in human pathogens, including Candida spp. (Hull, Parker 
et al. 2012; Xiang, Liu et al. 2013) and Aspergillus fumigatus (Lelièvre, Groh et al. 2013), 
and is a serious problem in agricultural systems (Cools and Fraaije 2013). Fungicide 
resistance has been associated with the alteration and overexpression of the CYP51 protein 
and enhanced triazole efflux (Sanglard, Kuchler et al. 1995; Nakaune, Adachi et al. 1998; 
Gisi, Chin et al. 2000; Ma and Michailides 2005; Cools and Fraaije 2008; Hulvey, Popko Jr 
et al. 2012; Cools and Fraaije 2013).  
 
Two earlier studies have noted changes in Bgh CYP51 coding sequence (Y136F and K147Q) 
present in isolates less responsive to triazoles (Délye, Bousset et al. 1998; Wyand and Brown 
2005). As K147Q was never found alone and Y136F was found in isolates with both low and 
high levels of triadimenol resistance, the exact sensitivity shift afforded by each was unclear. 
In these cases field resistance arose despite a complex pattern of simultaneous use of many 
fungicide modes of action (MOA) and the widespread use of other pathogen counter 
measures. In contrast, in WA the vast majority of the area was sown to susceptible cultivars 
and only a single class of fungicide was used (Tucker, Lopez-Ruiz et al. 2014). This has 
allowed us to chart the development of a major epidemic. 
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Many growers from southern WA reported a reduction in the effectiveness of triazoles in 
controlling barley powdery mildew outbreaks (GRDC 2012). Tebuconazole-containing 
formulations have been popular due to their  low cost and spectrum of activity (Tucker, 
Lopez-Ruiz et al. 2014). Since 2005, accounts of mildew infection on barley sprayed with 
tebuconazole formulations have extended over much of the southern agricultural region with 
the frequency of reports increasing in recent years (Lord and Kehoe 2014).  
In this study we have determined the sensitivity of Australian Bgh isolates to triazole 
fungicides registered in WA. Sequencing of the CYP51 coding region in a subset of isolates 
revealed four unique genotypes. We have characterised the impact of these mutations on 
triazole sensitivity by in vitro assays and by heterologous expression in Saccharomyces 
cerevisiae. The results link variations in triazole sensitivities to changes in the CYP51 coding 
region that are predicted to alter the heme binding pocket. Protein structural modelling and 
triazole docking was able to rationalise the observation of both positive and negative cross 
resistance. The results clearly demonstrate how misuse of pesticides leads directly to 
resistance in Bgh and validate how molecular methods accelerate the discovery of solutions. 
Materials and Methods 
Blumeria graminis f. sp. hordei  
Isolates 
One hundred and nineteen Bgh isolates were collected from Australia from 2009 to 2013 
(Figure 1, Supporting Information Table S1). Isolates from Wagga Wagga, Tamworth (New 
South Wales) and Launceston (Tasmania) were supplied by the Department of Environment 
and Primary Industries, Victoria. Isolate purification, sub-culturing and assessments of 
growth were performed according to Tucker (2013).  
Fungicide sensitivity assays 
Fungicide sensitivities were determined in vitro by assessing growth of 18 Bgh isolates on 
susceptible (cv. Baudin) barley leaves inserted into fungicide-amended media with a no 
fungicide control. Commercial formulations of triazoles currently registered for Bgh control – 
Laguna (720g L-1 tebuconazole, Sipcam), Flutriafol (250g L-1 flutriafol, Imtrade Australia), 
Opus (125g L-1 epoxiconazole, Nufarm), Alto (100g L-1 cyproconazole, Nufarm), Tilt (418g 
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L-1  propiconazole, Syngenta), Proline (410g L-1 prothioconazole, Bayer Crop Science), Triad 
125 (125g L-1 triadimefon, Farmoz) and Jockey Stayer (167g L-1 fluquinconazole, Bayer Crop 
Science) were incorporated into agar amended with 50mg L-1 of benzimidazole (Chan and 
Boyd 1992). Middle sections of 10 day old seedlings were excised with each tip inserted 
abaxial side up into fungicide amended agar. Each isolate was used to inoculate three 
replicates on subsequent weeks with conidia dislodged 24h before use to promote fresh 
growth. Conidal suspensions were collected on glossy black paper and blown into a 1.5m 
infection tower to ensure even inoculation. Following seven days growth at 20±2°C subject to 
a 12:12 h light :dark photoperiod  the growth of each isolate and fungicide concentration was 
assessed using a 0-4 infection type (IT) scale adapted from Czembor (2000). Each pustule 
formation (or lack thereof) was assigned an IT and the average for each isolate and fungicide 
concentration pair was determined. Both the average IT and concentration was log 
transformed, % inhibition calculated and plotted against  the transformed concentration to 
determine the regression equation and correlation coefficient.  The mean 50% effective 
concentration (EC50) and strength of the linear relationship between the two variables was 
determined. Resistance factors (RF) were calculated as the fold change in the average EC50 of 
T509 CYP51 isolates compared to S509 isolates (Supporting Information Table S2). Data 
analysis was conducted in JMP, v10 (SAS Institute Inc. Cary, NC). 
CYP51 sequencing  
DNA isolations were performed using a BioSprint 15 DNA Plant Kit (Qiagen) following the 
manufacturer’s instructions. The wild type Bgh DH14 isolate (GenBank accession no. 
AJ313157) was used to design primers (Supporting Information Table S3) covering the 
length of the Bgh CYP51 (Bgh51) gene (Supporting Information Fig. S1). Both the coding 
sequence and promoter region of 76 isolates were sequenced using Sanger sequencing and 
aligned in Geneious v 5.5 (Biomatters). A homology search was conducted between the 
Australian Bgh CYP51 genotypes with other published CYP51 variants. All sequences have 
been submitted to GenBank (Accession no. KM016902, KM016903, KM016904 and 
KM016905). By employing a high-throughput method of S509 and T509 allele detection 
((digesting the amplicon of Bgh51_3F and Bgh51_3R with Hpy8I) (Supporting Information 
Table S3)), the CYP51 509 genotype of all 119 isolates was obtained. 
Yeast Phenotyping 
Strains and complementation of transformants  
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Synthesis of the wild type (wt) DH14 (Accession no. AJ313157) CYP51 gene (Bgh51wt) was 
carried out by GENEWIZ Inc. (South Plainfield, NJ). Terminal restriction enzyme 
recognition sites for Kpn1 and EcoR1 were added at the 5’ and 3’ ends respectively. The 
pYES-Bgh51wt expression plasmid was constructed by cloning the synthesized Bgh51wt into 
the pYES3/CT vector (Invitrogen, Carlsbad, CA). The full length Bgh51wt gene in pYES-
Bgh51wt was sequenced to ensure the validity. Transformations into S. cerevisiae strain 
YUG37:erg11 (MATa ura3-52 trp1-63 LEU2::tTa tetO-CYC1::ERG11) with native Cyp51 
gene under the control of a tetO-CYC1promoter, repressed in the presence of doxycycline 
(Parker, Merkamm et al. 2008). All complementation assays were preformed according to 
Cools et al (2010) with photographs taken following 72h of growth at 20°C (Supporting 
Information Fig. S2). Mutations found in Bgh51 of Australian isolates were introduced into 
pYES-Bgh51wt through a QuickChange II site-directed mutagenesis kit (Stratagene, La Jolla, 
CA). 
Comparative growth rate assay of transformants  
The growth rate of transformants was assessed using Gen 5 data analysis software (BioTek 
Instruments, Inc. Winooski, VT) where duplicate cultures of replicate transformants were 
grown in SD GAL + RAF medium (SD medium) overnight at 30°C. One hundred microliters 
of each overnight culture, at 105 cells ml-1, was used to inoculate 3 wells containing 200μl SD 
medium ±3μg ml-1 doxycycline. Cultures were incubated without light at 30°C, and the 
optical density at 600nm (OD600) was measured every 15min for 12 days in a Synergy
TM HT 
Multi-Mode Microplate Reader (BioTek Instruments, Inc Winonski, VT). The mean 
maximum growth rate for each strain ± doxycycline was determined on the basis of the 
greatest increase in OD over a 2h period (Supporting Information Table S4). 
Fungicide sensitivity assays 
Sensitivity assays were carried out as described by Cools et al. (2010) using pure samples of 
tebuconazole, cyproconazole, propiconazole, epoxiconazole, fluquinconazole, triadimefon, 
flutriafol and desthio-conazole with a fungicide free control. It should be noted that as 
prothioconazole must be metabolised in plant tissue for it to be active (Parker, Warrilow et al. 
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Structural modelling of Bgh51wt and mutant forms was undertaken using an automated 
homology modelling platform as previously described for Z. tritici CYP51 (Mullins, Parker et 
al. 2011). Ligand docking of epoxiconazole and fluquinconazole were also carried out as 
previously described (Mullins, Parker et al. 2011). The volume of the heme cavity of the wild 
type and variant protein models was determined using Pocket-Finder (Leeds, UK) which is a 




Eighteen Bgh isolates were assessed for susceptibility to currently registered fungicides for 
barley powdery mildew control in WA. Distinct patterns of resistance were observed and the 
triazole target gene – Cyp51 was sequenced to ascertain whether mutational events caused the 
variance in the response to triazoles. Primers were designed covering both the coding and 
promoter region of the single CYP51 gene (Becher and Wirsel 2012) in Bgh (Supporting 
Information Table S3, Supporting Information Fig. S1). The Bgh51wt DH14 sequence was 
used as a reference (Spanu, Abbott et al. 2010). No indels were found in the promoter region 
of any isolate (data not shown). The Cyp51 coding region was sequenced from 76 Australian 
isolates collected over from 2009 to 2013, including three from the east of Australia. Several 
synonymous and non-synonymous changes were identified (Supporting Information Fig. S3). 
All three isolates from the east of Australia carried two synonymous changes at nucleotides 
81 and 1475, which were absent in WA isolates. All the Australian isolates carried the 
tyrosine to phenylalanine mutation at amino acid position 136 (Y136F) previously seen by 
Delye et al. (Délye, Bousset et al. 1998) and Wyand and Brown (Wyand and Brown 2005). 
Further non-synonymous mutations were found; K171E, M301I, R327G and S509T in 
various combinations (Figure 2). Considering only the non-synonymous changes, four novel 
Bgh51 genotypes were distinguished. Isolates collected in WA were either F136/T509 
(genotype 2) or F136/I301/G327/T509 (genotype 4) while isolates from other Australian 
states were either F136/E171 (genotype 3) or F136 (genotype 1). Mutations I301 and G327 
were consistently found in the same isolates (Figure 2). 
There was both spatial and temporal variation in the frequency of genotypes (Figure 1, 
Supporting Information Table S1). All isolates collected in 2009 were wild type at CYP51 
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position 509. The proportion of S509 isolates collected declined dramatically over subsequent 
seasons to as low as 0.07 in 2011 (data not shown). Ninety nine of the 116 WA isolates 
analysed contained the T509 mutation. These mutants were found in all major WA barley 
growing areas (Figure 1). 
Triazole sensitivities of Bgh isolates 
The sensitivities of Bgh isolates were determined using detached barley leaves inserted into 
triazole-amended agar. The results varied between genotype and fungicide (Figure 3, 
Supporting Information Fig. S4). There were no significant differences between isolates of 
genotype 1and 3 or between isolates that were genotype 2 or 4. For this reason we focussed 
on whether isolates contained the S509T mutation. Isolates of genotype 1 and 3 were 
consistently more sensitive to all foliar fungicides tested. The RFs were highest for genotypes 
2 and 4 in the presence of tebuconazole and flutriafol (Figure 3). For fluquinconazole (used in 
WA solely as a seed formulation), the T509 isolates were marginally more sensitive 
suggesting negative cross resistance to this compound. Unfortunately, due to quarantine 
restrictions we were not able to phenotype the wild type DH14 isolate. 
Heterologous expression in yeast 
The Bgh51wt gene (i.e. as found in DH14) was synthesized and cloned into S. cerevisiae 
YUG37:erg11 with a doxycycline repressible promoter. The S. cerevisiae Bgh51wt 
transformant was able to grow in the presence of doxycycline (Supporting Information Fig. 
S2). There was no significant difference in the growth rates of all variants in the absence of 
doxycycline. However two S. cerevisiae Bgh51 variants had significantly lower rates of 
growth in the presence of doxycycline (pYES-Bgh51_Y136F/S509T/R327G and pYES-
Bgh51_Y136F/M301I/R327G/S509T) and were removed from all further in vitro analysis. 
The triazole sensitivities of S. cerevisiae strains expressing Bgh51 variants which restored 
growth on doxycycline-amended medium were determined (Supporting Information Table 
S5) and resistance factors were calculated (Table 1). Modest RFs were associated with the 
solo K171E and M301I mutations. RFs for the S509T mutation varied from 0.5 for 
fluquinconazole to 12.4 for propiconazole.  Resistance for the solo Y136F mutation, which 
has been found in nature in Bgh, were also modest except for fluquinconazole having a RF of 
9.7, confirming the marginal cross resistance detected in the detached leaf assays. The 
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combination of F136 and T509 had much larger RFs of 340.6 for propiconazole and 33.2 for 
tebuconazole.  
For many mutations fluquinconazole displayed outlier results. The RF for Y136F was 
strongly positive (9.7) whereas the RF for all other mutation combinations was 0.1 to 0.5  
indicating greater sensitivity than the wild type construct  
Structural modelling 
The mutant protein variants of all Bgh51 genotypes were structurally modelled (Supporting 
Information Fig S5). The effect of each mutational change on the volume of the heme cavity 
and distance from key amino acids around the cavity entrance was determined (Table 2). 
Modest volume increases were observed with the solo mutations; a 17.7% increase with 
K171E and 39.6% increase in volume with Y136F. Mutation S509T was an exception, with 
an increase in volume of 73.2% compared to that of the wild type model. The combination of 
F136/T509 gave a more substantial increase of 83.9%.  
 
Table 2 also shows the estimated distances between Y222 and S506, which measures along 
the region of the access channel adjacent to the triazole binding site. Unlike the volume of the 
heme cavity, single mutational changes such as K171E and M301I decreased the diameter of 
the access channel by 7.8% and 6.6% respectively, compared to the wild type. The major 
conformation change is brought about through the acquisition of the Y136F mutation, which 
restricts the channel opening of the wild type model by 28.5%. The combination of F136 and 
T509 in a single model only slightly decreases the channel over the Y136 model to 28.7% of 
that of Bgh51wt. 
 
The predicted binding pocket size and the diameter of the access channel were combined to 
elucidate the overall change of each genotype compared to the wild type. It appears that each 
of the two mechanisms can operate singly or in combination. Notably the change in heme 
cavity volume of the less sensitive S509T mutant had an increase of 73.2% over that of the 
wild-type, compared to an increase of 39.6% for the Y136F mutant. The inverse relationship 
was observed between decreases in the diameter of the substrate access channel Here S509T 
mutation, which rendered constructs less sensitive to Tebuconazole, resulted in a 20.4% 
restriction in the diameter of the access channel over the wild-type compared to a more 
marked restriction of -28.5% in the more sensitive Y136F mutant. However these two protein 
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characteristics combined in the single Y136F + S509T genotype may well be responsible for 
the exceptional RF observed especially in the case of Tebuconazole.  In addition 
conformation of a loop of beta turn running from S505 to F508 is markedly different in the 
Y136F genotype to that of the wild type, with the result that it projects into the cavity. A 
similar constriction is observed for the F136/T509 mutant (Supporting Information Fig. S5b). 
However, in this case it is also accompanied by a substantial increase in cavity volume (Table 
2), consistent with the exceptional resistance factors observed. It is interesting to note that 
this loop is adjacent to S509. This supports the idea that the structural changes brought about 
by the Y136F mutation on its own may exert selective pressure on the 509 position, leading 
to the F136/T509 mutant. 
 
Fluquinconazole docking studies were carried out to elucidate the mechanistic reasons for the 
cross resistance patterns (Figure 4b). In the wild type structure, the binding site of 
fluquinconazole is bordered by amino acids Y122 and Y222. It appears that the position of 
Y122 is particularly important in establishing the correct orientation of fluquinconazole so as 
to be coordinated by the heme. This arrangement is disrupted in the Y136F mutant, where 
Y122 and S506 prevent fluquinconazole accommodation (Figure 4b). With the Y136F/S509T 
mutant, Y122 is positioned similarly to the wild type, allowing accommodation of 
fluquinconazole as in the wild type. Here S506 borders the binding site and is predicted to 
interact with the fluquinconazole ligand (Figure 4c). Thus it appears the relative 
inconsistency of the Y136F mutant and enhanced selection of the Y136F/S509T double 
mutant can be explained by the 3D docking results. 
Discussion 
Studies best exemplified by the wheat pathogen Z. tritici, have discussed the relationship 
between mutational changes in CYP51 with failures of triazole fungicides in the field. 
Triazoles have been used since the first registration of triadimefon in 1973 in the UK (Russell 
2005). Twenty years after its introduction, Z. tritici isolates were found with CYP51 changes 
conferring reductions in sensitivity (Cools and Fraaije 2013). Subsequently, numerous azoles 
have been introduced and 34 additional CYP51 mutations have been identified (Cools and 
Fraaije 2013). This long history and the recent identification of mutations has made it 
difficult to discern cause and effect. The situation in WA is simple: triazole use has been 
widespread since 2004 and the first reports of resistance date from 2005.  
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Analysis of CYP51of Australian Bgh isolates collected from 2009 to 2013 revealed four 
genotypes. The in vitro sensitivities of isolates from different genotypes varied between the 
triazoles tested. Bgh isolates with genotypes harbouring the S509T mutation were less 
sensitive to all the foliar fungicides used on barley in WA. In the case of fluquinconazole 
(which is only currently registered in WA as a seed treatment) isolates harbouring the T509 
CYP51 allele were more sensitive than their S509 counterparts. The Y136F mutation was 
found in all isolates examined including those from the east of Australia. As yet there have 
been no reports of field failure in this region.  
This mutation was previously correlated with strong resistance to triadimenol (Wyand and 
Brown 2005). We cannot test the wild type CYP51 Bgh isolate in Australia due to quarantine 
restrictions. Y136F expression in yeast showed modest but significant decreases in sensitivity 
to most triazoles (Table 1). We therefore assume that there would be small differences in 
field efficacy that are unlikely to be noticeable. This suggests that even the limited fungicide 
use in the east of Australia has been sufficient to select for this mutation (Murray and 
Brennan 2010). If the new S509T mutation integrates into eastern populations of Bgh or is 
selected in situ, tebuconazole breakdown is inevitable and may no longer be an option for 
disease control in Australia. 
Figure 3 compares the in vitro EC50 with the field rates for triazole foliar fungicides. 
Registered maximal application rates range from 125g ha -1 for tebuconazole, flutriafol, 
propiconazole and triadimefon to 65g ha -1 for epoxionzaole, cyproconazole and 
prothioconazole. It is clear that the high EC50 for tebuconazole means that strains harbouring 
the Y136F/S509T genotype are essentially resistant to field rates of this fungicide as the dose 
rate safety margin is less than for other registered compounds. In yeast, assays are more 
precise and there was a consistent pattern whereby large RFs were associated with strains 
carrying both the Y136F and S509T mutations for all triazoles except fluquinconazole.  
A search was conducted on the CYP51 mutations in other fungal species reported as 
conferring a reduction in triazole sensitivity. The Bgh51 amino acid sequence of Australian 
genotypes was aligned with Z. tritici CYP51 (Figure 2). Mutational changes at the amino 
acids 136, 301, 327 and 509 fall in regions conserved between Bgh and Z. tritici (Becher and 
Wirsel 2012). Amino acids 136 and 509 in Bgh51 correspond to 137 and 524 in Z. tritici 
which have previously been correlated with reductions in triazole sensitivity (Cools, Mullins 
et al. 2011). In our studies the combination of Y136F/S509T encoded a CYP51 with a marked 
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decrease in sensitivity to tebuconazole that can account for the field failure (Figure 3). The 
relationship between the combination of these two mutations and reduced efficacy was 
confirmed by the yeast expression data. Increases in heme cavity volume and restriction of 
the access channel in Y136F/S509T protein models correlate well with the significant RF 
obtained (Figure 5). A high RF was also observed for the Y136F/S509T Bgh Cyp51 construct 
when expressed in the yeast system, the results of which did not reflect data obtained in the in 
planta assays nor colloquial observations made in the field. Perhaps the reason propiconazole 
is still providing sufficient mildew control in the field is due to the large safety margin 
between the dose required for effective control and the dose registered for use. 
Both positive and negative selection was observed in the in vitro Bgh and yeast expression 
studies. The widespread use of tebuconazole on very susceptible cultivars appears to account 
for the selection of the more damaging Y136F/S509T combination since 2005 (APVMA 
2014). The prior selection of Y136F, although insignificant in field terms, paved the way for 
the selection of further mutations in isolates, capable of surviving field application rates of 
the most widely used fungicides. 
 
Although all triazole compounds contain the 1, 2, 4 triazole ring, the adjoining structures are 
highly variable and directly reflect specificity of action. After examination of the structure of 
the triazoles employed in this study, it is clear that several compounds have chemical 
elements that are common to more than one compound (Supporting Information Fig S6). 
Tebuconazole, Cyproconazole, Epoxiconazole and Triadimefon all comprise the usual 
triazole backbone with an adjoining six carbon unsaturated heterocyclic ring with an attached 
chlorine molecule. Flutriafol, Epoxiconazole, and Fluquinconazole have the same six 
membered ring except with an attached Fluorine atom. Propiconazole is the only fungicide 
tested that possesses a 1, 3 dioxolane ring joined to the characteristic 1, 2, 4 triazole 
backbone. Theoretically, the presence of this unique triazole moity may affect propiconazole 
binding and/or specificity in the yeast system compared with the in planta assays, possibly 
resulting in the increased RF for Propiconazole in the heterologous expression system.  
Structural modelling suggests that there are two main mechanisms that underpin the 
emergence of triazole resistance associated with mutational changes in Bgh51. The first 
mechanism is similar to that observed in Z. tritici CYP51 (Mullins, Parker et al. 2011), where 
the gross volume of the heme cavity increases with successive mutations (Table 2). There 
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appears to be a correlation between the increase in cavity volume and the RFs reported in 
table 1. It is likely that any increase in heme cavity volume would perturb the orientation of 
the triazole ligand and hence its binding to the heme. This therefore isolates the smaller to 
medium size triazole ligands such as tebuconazole and epoxiconazole. 
 
The second mechanism at play provides a means of linking structural changes with 
phenotypic changes in a measurable way. Changes in distances between specific pairs of 
residues that border the cavity result in changes to the diameter of the access channel. The 
limiting of the binding surface between Y222 and S312 appears to correlate well with 
resistance to tebuconazole. The narrowing of the access channel between Y222 and S506 
correlates particularly well, especially when tempered by consideration of the effects of each 
variant on the cavity volume. This is demonstrated by the result obtained when the product of 
the percent change in the heme cavity volume is multiplied by the percent change in the 
distance between Y222 and S506 (Figure 5). All the variants that contain F136 demonstrate a 
substantially reduced distance between Y222 and S506 (Table 2). When one of the 
mechanisms is employed, moderate resistance factors are observed (F136 (access channel 
narrowing); T509 (substantial increase in cavity volume)). Although, when both mechanisms 
act together there is a strong correlation between the structural changes and the very high 
resistance factors of the F136/T509 mutants in the presence of tebuconazole. The in silico 
creation of Bgh51wt and mutant CYP51 protein variants opens the possibility of future 
docking studies employing novel or unregistered triazole fungicides. This will allow the 
prediction the effectiveness of any new product prior to in planta testing. Furthermore, we 
can now recommend bespoke spray regimes depending on which Bgh51 genotype is present 
in the field.  
 
One of the major resistance strategies used for fungicides is to mix active compounds with 
different MOA (van den Bosch, Oliver et al. 2014). The concept here is that isolates with 
mutations conferring resistance to one fungicide will most likely still be sensitive to the 
second mixing partner (van den Bosch, Oliver et al. 2014).Negative cross-resistance within a 
single MOA group has been shown in vitro with mutant Z. tritici isolates which are highly 
resistant to tebuconazole but fully susceptible to prochloraz (Fraaije, Cools et al. 2007; 
Leroux, Albertini et al. 2007). The negative cross-resistance shown in both the Bgh in vitro 
(Figure 3) and yeast expression studies (Table 1) was confirmed using in silico protein 
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docking studies. Here the single Y136F mutation substantially impaired the binding of 
fluquinconazole (Figure 4). In contrast, the binding of fluquinconazole at the docking site of 
the Y136F/S509T protein model was much akin to that of the wild-type.  Fluquinconazole 
would be expected to efficiently select for Y136F but counter select the more T509 
genotypes. We therefore suggest that fluquinconazole be trialled as a means to control this 
epidemic. Nonetheless there is an immediate need for the registration of formulations with 
novel MOA and breeding of cultivars with durable resistance.  Even if fluquinconazole 
effectively counter selects the S509T mutation, its efficacy would more than likely be short 
lived given Bgh’s propensity for adaptation (data not shown). However these studies do 
provide a means of testing the likely efficacy of any currently available triazole and will 
permit the in silico exploration of novel triazoles. The affinity for the wild type and any 
mutant CYP51 variants can now be compared thereby fast tracking the design, development 
and registration of new compounds not affected by current mutations.  
The widespread use of highly susceptible varieties and the repeated use of a single MOA 
fungicide was a perfect recipe for an epidemic of fungicide resistance. A review covering the 
decade from 1999 to 2009 estimated that Bgh in WA caused losses of AU$30M p.a. (Murray 
and Brennan 2010). The area sown to barley was approximately 1.3 m ha (ABARES 2014) 
and 55% of the delivered grain was from cultivars rated as susceptible to powdery mildew 
infection (CBH 2014). The epidemic of highly virulent (Tucker, Jayasena et al. 2013) and 
tebuconazole resistant Bgh in WA is estimated to have reduced average yield from 2.91 t/ha 
to 1.76 t/ha (NVT 2014) and reduce the quality of grain from malt to feed grade. Based on 
these figures, and an average grain price of $268/t for malt barley and $231/t for feed 
(DailyGrain 2014), the epidemic of WA tebuconazole resistant Bgh caused at least an average 
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Desthio Desthioconazole 
Epoxi  Epoxiconazole 
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Prothio Prothioconazole 
Teb  Tebuconazole 
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Figure Legends 
Figure 1: Sample sites of Bgh isolates collected from Australia. Black triangles indicate 
mutant T509 CYP51 isolates (n = 119). Grey triangles indicate isolates with CYP51 genotype 
S509 (n = 24). Numbers within triangles indicate isolates collected at each site.  
Figure 2: Sequence alignment of fragments of the CYP51 protein family. Changes found in 
Australian Bgh isolates from wild-type DH14 (GenBank: CAC85622, Wyand and Brown, 
2005) are indicated in black. Numbers represent amino acid positions with assigned 
genotypes (Gen) given. Bgh isolates Pshk1 and Pshk2 from west Australia , Frnk1 from New 
South Wales and Strl1 from Tasmania are aligned with Zymoseptoria tritici (Z. tr) isolate 
ST1 (GenBank: AAU43734, Cools and Parker et al. 2010). Boxes indicate conserved regions. 
Figure 3: Box plots of the EC50 (μg mL
-1) of a collection of Australian Bgh isolates that are 
wild-type (filled) and mutant (empty) at amino acid position 509 of CYP51. Numbers indicate 
the resistance factor (RF) of T509 over S509 isolates. Field application rates (g ha-1) are 
given as black bars.  
Figure 4: Docking of fluquinconazole in Blumeria graminis f. sp. CYP51. 
A) Wild type CYP51, showing bound fluquinconazole (in light green, centre) and steric 
interaction with Y122 (surface shown as mesh). B) The Y136F mutant, showing 
encroachment of Y122 and S506 (surface shown as mesh) upon the docking site of 
fluquinconazole, indicating that the compound cannot be bound at that location.  C) The 
Y136F-S509T mutant, showing orientation of Y122 similar to wild type and predicted 
interaction with S506 (shown in yellow).  
Figure 5: Correlation between tebuconazole resistance factor (RF) of pYES-
Bgh51_Y136F/S509T and the product of the change in the volume of the heme cavity 
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Supporting Information  
Supporting Information Table S1: Details of collection and CYP51 genotype of the seventy-
three Bgh isolates sequenced using Sanger technology in this study. 
Supporting Information Table S2: Average in vitro EC50 and resistance factors of T509 and 
S509 Bgh51 isolates when exposed to currently registered triazoles in WA. 
Supporting Information Table S3: Primers used for sequencing and site-directed mutagenesis. 
Supporting Information Fig. S1: Binding position of primers used to sequence the length of 
Bgh51 including the 5’ promoter region. 
 
Supporting Information Fig. S2: Complementation of S. cerevisiae strain YUG37:erg11 with 
wild type (Bgh51wt) and mutated variants.  
Supporting Information Table S4: Growth rate analysis of S. cerevisiae YUG37:erg11 
transformants. 
 
Supporting Information Fig. S3: Nucleotide alignment of the CYP51 gene of five isolates of 
Bgh. 
Supporting Information Fig. S4: Average in vitro EC50 (μg mL
-1) of Australian Bgh isolates 
from four distinct genotypes 1 – F136, 2 – F136/T509, 3 – F136/E171 and 4 – 
F136/I301/G327/T509. 
 
Supporting Information Table S5: EC50 and resistance factors of the pYES-Bgh51 yeast 
mutants when exposed to currently registered triazoles in Western Australia. 
 
Supporting Information Fig. S5: Structural modelling of Bgh CYP51.   
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Teb Epoxi Propi Desthio Cyp Flut Triad Fluquin 
pYES-Bgh51_Y136F 1.1 3.7 1.6 3.3 1.0 1.4 1.5 9.7 
pYES-Bgh51_K171E 0.9 1.4 0.6 2.1 0.9 1.0 0.9 0.2 
pYES-Bgh51_M301I 0.9 1.8 2.1 0.2 0.7 0.5 0.5 0.1 
pYES-Bgh51_S509T 3.7 7.3 12.4 1.2 2.1 2.7 3.6 0.5 
pYES-Bgh51_Y136F/K171E 1.3 2.4 1.9 0.9 0.9 1.3 3.3 0.2 
pYES-Bgh51_Y136F/S509T 33.2 18.5 340.6 0.8 3.2 10.5 23.8 0.2 
pYES-
Bgh51_Y136F/S509T/M301I 2.3 4.9 2.8 0.1 0.8 1.9 5.7 <0.1 
aNumbers refer to amino acid positions in Bgh. Resistance factors (RF) were calculated from 
the mean EC50 values of eight independent replicates. RF <1 indicates greater sensitivity than 
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Table 2: Measurements of heme cavity volume and key inter-residue distances in wild-type 
















Wild-type 1809 - 12.862   
Y136F 2526 +39.6% 9.202 -28.5% 0.113 
K171E 2130 +17.7% 11.861 -7.8% 0.014 
M301I 2573 +42.2% 12.015 -6.6% 0.028 
R327G 2607 +44.1% 12.074 -6.1% 0.027 
S509T 3134 +73.2% 10.233 -20.4% 0.149 
Y136F/K171E 2334 +29.0% 10.870 -15.5% 0.045 
Y136F/S509T 3327 +83.9% 9.294 -28.7% 0.241 
Y136F/M301I/R327G/S509T 2181 +20.6% 9.960 -22.6% 0.047 
 
aΔHCV – change in heme cavity volume. 
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